<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">89690</article-id><article-id pub-id-type="doi">10.7554/eLife.89690</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.89690.4</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Binding of <italic>LncDACH1</italic> to dystrophin impairs the membrane trafficking of Nav1.5 protein and increases ventricular arrhythmia susceptibility</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Xue</surname><given-names>Genlong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund10"/><xref ref-type="other" rid="fund11"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Yang</surname><given-names>Jiming</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0007-5152</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Zhang</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Ruixin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Desheng</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4884-745X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Tian</surname><given-names>Tao</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Jialiang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Xiaofang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Changzhu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Xingda</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Jiqin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Shen</surname><given-names>Kewei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Xuening</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Guohui</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Xuan</surname><given-names>Lina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Shan</surname><given-names>Hongli</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Lu</surname><given-names>Yanjie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Baofeng</surname><given-names>Yang</given-names></name><email>yangbf@ems.hrbmu.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Pan</surname><given-names>Zhenwei</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1011-0954</contrib-id><email>panzw@ems.hrbmu.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con21"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05jscf583</institution-id><institution>Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/055w74b96</institution-id><institution>The Institute of Heart and Vascular Diseases, Department of Cardiology, and Central Laboratory, the First Affiliated Hospital of Dalian Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Dalian</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/006teas31</institution-id><institution>Shanghai Frontiers Science Research Center for Druggability of Cardiovascular noncoding RNA, Institute for Frontier Medical Technology, Shanghai University of Engineering Science</institution></institution-wrap><addr-line><named-content content-type="city">Shanghai</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02drdmm93</institution-id><institution>Research Unit of Noninfectious Chronic Diseases in Frigid Zone, Chinese Academy of Medical Sciences</institution></institution-wrap><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05jscf583</institution-id><institution>NHC Key Laboratory of Cell Transplantation. The First Affiliated Hospital of Harbin Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Colecraft</surname><given-names>Henry M</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00hj8s172</institution-id><institution>Columbia University</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Swartz</surname><given-names>Kenton J</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01s5ya894</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>07</day><month>01</month><year>2025</year></pub-date><volume>12</volume><elocation-id>RP89690</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-06-27"><day>27</day><month>06</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2021-02-04"><day>04</day><month>02</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.21203/rs.3.rs-156367/v1"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-09-01"><day>01</day><month>09</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.89690.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-05-03"><day>03</day><month>05</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.89690.2"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-07-02"><day>02</day><month>07</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.89690.3"/></event></pub-history><permissions><copyright-statement>© 2023, Xue, Yang, Zhang et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Xue, Yang, Zhang et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-89690-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-89690-figures-v1.pdf"/><abstract><p>Dystrophin is a critical interacting protein of Nav1.5 that determines its membrane anchoring in cardiomyocytes. Long noncoding RNAs (lncRNAs) are involved in the regulation of cardiac ion channels, while their influence on sodium channels remains unexplored. Our preliminary data showed that lncRNA-<italic>Dachshund</italic> homolog 1 (<italic>lncDach1</italic>) can bind to dystrophin, which drove us to investigate if <italic>lncDach1</italic> can regulate sodium channels by interfering with dystrophin. Western blot and immunofluorescent staining showed that cardiomyocyte-specific transgenic overexpression of <italic>lncDach1</italic> (<italic>lncDach1</italic>-TG) reduced the membrane distribution of dystrophin and Nav1.5 in cardiomyocytes. Meanwhile, peak <italic>I</italic><sub>Na</sub> was reduced in the hearts of <italic>lncDach1</italic>-TG mice than wild-type (WT) controls. The opposite data of western blot, immunofluorescent staining and patch clamp were collected from <italic>lncDach1</italic> cardiomyocyte conditional knockout (<italic>lncDach1</italic>-cKO) mice. Moreover, increased ventricular arrhythmia susceptibility was observed in <italic>lncDach1</italic>-TG mice in vivo and ex vivo. The conservative fragment of <italic>lncDach1</italic> inhibited membrane distribution of dystrophin and Nav1.5, and promoted the inducibility of ventricular arrhythmia. Strikingly, activation of <italic>Dystrophin</italic> transcription by dCas9-SAM system in <italic>lncDach1</italic>-TG mice rescued the impaired membrane distribution of dystrophin and Nav1.5, and prevented the occurrence of ventricular arrhythmia. Furthermore, <italic>lncDach1</italic> was increased in transaortic constriction (TAC) induced failing hearts, which promoted the inducibility of ventricular arrhythmia. And the expression of <italic>lncDach1</italic> is regulated by hydroxyacyl-CoA dehydrogenase subunit beta (hadhb), which binds to <italic>lncDach1</italic> and decreases its stability. The human homologue of <italic>lncDACH1</italic> inhibited the membrane distribution of Nav1.5 in human iPS-differentiated cardiomyocytes. The findings provide novel insights into the mechanism of Nav1.5 membrane targeting and the development of ventricular arrhythmias.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>LncDACH1</kwd><kwd>dystrophin</kwd><kwd>Nav1.5</kwd><kwd>ventricular arrhythmia</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100012166</institution-id><institution>National Key Research and Development Program of China</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Xue</surname><given-names>Genlong</given-names></name><name><surname>Zhang</surname><given-names>Yang</given-names></name><name><surname>Yang</surname><given-names>Ying</given-names></name><name><surname>Zhang</surname><given-names>Ruixin</given-names></name><name><surname>Li</surname><given-names>Desheng</given-names></name><name><surname>Tian</surname><given-names>Tao</given-names></name><name><surname>Li</surname><given-names>Jialiang</given-names></name><name><surname>Zhang</surname><given-names>Xiaofang</given-names></name><name><surname>Li</surname><given-names>Changzhu</given-names></name><name><surname>Li</surname><given-names>Xingda</given-names></name><name><surname>Yang</surname><given-names>Jiqin</given-names></name><name><surname>Shen</surname><given-names>Kewei</given-names></name><name><surname>Guo</surname><given-names>Yang</given-names></name><name><surname>Liu</surname><given-names>Xuening</given-names></name><name><surname>Yang</surname><given-names>Guohui</given-names></name><name><surname>Xuan</surname><given-names>Lina</given-names></name><name><surname>Shan</surname><given-names>Hongli</given-names></name><name><surname>Lu</surname><given-names>Yanjie</given-names></name><name><surname>Baofeng</surname><given-names>Yang</given-names></name><name><surname>Pan</surname><given-names>Zhenwei</given-names></name><name><surname>Yang</surname><given-names>Jiming</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Xue</surname><given-names>Genlong</given-names></name><name><surname>Zhang</surname><given-names>Yang</given-names></name><name><surname>Yang</surname><given-names>Ying</given-names></name><name><surname>Zhang</surname><given-names>Ruixin</given-names></name><name><surname>Li</surname><given-names>Desheng</given-names></name><name><surname>Tian</surname><given-names>Tao</given-names></name><name><surname>Li</surname><given-names>Jialiang</given-names></name><name><surname>Zhang</surname><given-names>Xiaofang</given-names></name><name><surname>Li</surname><given-names>Changzhu</given-names></name><name><surname>Li</surname><given-names>Xingda</given-names></name><name><surname>Yang</surname><given-names>Jiqin</given-names></name><name><surname>Shen</surname><given-names>Kewei</given-names></name><name><surname>Guo</surname><given-names>Yang</given-names></name><name><surname>Liu</surname><given-names>Xuening</given-names></name><name><surname>Yang</surname><given-names>Guohui</given-names></name><name><surname>Xuan</surname><given-names>Lina</given-names></name><name><surname>Shan</surname><given-names>Hongli</given-names></name><name><surname>Lu</surname><given-names>Yanjie</given-names></name><name><surname>Baofeng</surname><given-names>Yang</given-names></name><name><surname>Pan</surname><given-names>Zhenwei</given-names></name><name><surname>Yang</surname><given-names>Jiming</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>CIFMS</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Xue</surname><given-names>Genlong</given-names></name><name><surname>Zhang</surname><given-names>Yang</given-names></name><name><surname>Yang</surname><given-names>Ying</given-names></name><name><surname>Zhang</surname><given-names>Ruixin</given-names></name><name><surname>Li</surname><given-names>Desheng</given-names></name><name><surname>Tian</surname><given-names>Tao</given-names></name><name><surname>Li</surname><given-names>Jialiang</given-names></name><name><surname>Zhang</surname><given-names>Xiaofang</given-names></name><name><surname>Li</surname><given-names>Changzhu</given-names></name><name><surname>Li</surname><given-names>Xingda</given-names></name><name><surname>Yang</surname><given-names>Jiqin</given-names></name><name><surname>Shen</surname><given-names>Kewei</given-names></name><name><surname>Guo</surname><given-names>Yang</given-names></name><name><surname>Liu</surname><given-names>Xuening</given-names></name><name><surname>Yang</surname><given-names>Guohui</given-names></name><name><surname>Xuan</surname><given-names>Lina</given-names></name><name><surname>Shan</surname><given-names>Hongli</given-names></name><name><surname>Lu</surname><given-names>Yanjie</given-names></name><name><surname>Baofeng</surname><given-names>Yang</given-names></name><name><surname>Pan</surname><given-names>Zhenwei</given-names></name><name><surname>Yang</surname><given-names>Jiming</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100012166</institution-id><institution>National Key R&amp;D Program of China</institution></institution-wrap></funding-source><award-id>2017YFC1307404</award-id><principal-award-recipient><name><surname>Pan</surname><given-names>Zhenwei</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>82070344</award-id><principal-award-recipient><name><surname>Pan</surname><given-names>Zhenwei</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81870295</award-id><principal-award-recipient><name><surname>Pan</surname><given-names>Zhenwei</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81730012</award-id><principal-award-recipient><name><surname>Pan</surname><given-names>Zhenwei</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81861128022</award-id><principal-award-recipient><name><surname>Pan</surname><given-names>Zhenwei</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution>Heilongjiang Touyan Innovation Team Program, and CAMS Innovation Fund for Medical Sciences</institution></institution-wrap></funding-source><award-id>2019-I2M-5–078</award-id><principal-award-recipient><name><surname>Baofeng</surname><given-names>Yang</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution>Dalian Medical Key Specialty Climbing Program Scientific Research Project</institution></institution-wrap></funding-source><award-id>2022DF014</award-id><principal-award-recipient><name><surname>Xue</surname><given-names>Genlong</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution>Liaoning Provincial Natural Science Foundation Project</institution></institution-wrap></funding-source><award-id>2023-BS-166</award-id><principal-award-recipient><name><surname>Xue</surname><given-names>Genlong</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>lncDACH1 is a novel regulator of sodium channel, which suppresses the membrane trafficking of Nav1.5 by disturbing the function of dystrophin.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The voltage-gated sodium channel mediates the 0 phase depolarizing inward sodium currents of cardiomyocytes (<xref ref-type="bibr" rid="bib17">Rook et al., 2012</xref>). The expression and function of the sodium channel is regulated at multiple levels encompassing gene mutation, post-transcriptional modification, post-translational modification, and protein trafficking etc (<xref ref-type="bibr" rid="bib17">Rook et al., 2012</xref>; <xref ref-type="bibr" rid="bib14">Marionneau and Abriel, 2015</xref>). The disruption of either process is arrhythmogenic and occasionally causes sudden death (<xref ref-type="bibr" rid="bib14">Marionneau and Abriel, 2015</xref>; <xref ref-type="bibr" rid="bib18">Ruan et al., 2009</xref>).</p><p>The membrane targeting and localization of the pore-forming subunit of sodium channel Nav1.5 was regulated by several interacting proteins such as ankyrin-G, MOG1, syntrophin, and dystrophin etc (<xref ref-type="bibr" rid="bib14">Marionneau and Abriel, 2015</xref>; <xref ref-type="bibr" rid="bib1">Abriel et al., 2015</xref>). Dystrophin is an intracellular protein that is encoded by the <italic>duchenne muscular dystrophy</italic> (<italic>DMD</italic>) gene (<xref ref-type="bibr" rid="bib11">Lapidos et al., 2004</xref>). It distributes mainly on the cellular membrane of skeletal muscle cells and cardiomyocytes, and acts as a scaffold for Nav1.5 (<xref ref-type="bibr" rid="bib7">Gavillet et al., 2006</xref>). In cardiomyocytes, <italic>Dmd</italic> controls the expression and membrane anchoring of Nav1.5. <xref ref-type="bibr" rid="bib7">Gavillet et al., 2006</xref> showed that knockout of dystrophin in cardiomyocytes reduced peak sodium current, Nav1.5 protein expression, and conduction velocity in mice. Subsequently, they confirmed that the knockout of dystrophin inhibits membrane distribution of Nav1.5 due to the disruption of dystrophin-syntrophin complex (<xref ref-type="bibr" rid="bib15">Petitprez et al., 2011</xref>).</p><p>LncRNAs are a new class of RNAs that are more than 200 nts long and possess little protein-coding property. (<xref ref-type="bibr" rid="bib16">Quinn and Chang, 2016</xref>) LncRNAs have been shown to regulate multiple biological processes and participate in the pathogenesis of various diseases including cardiac diseases (<xref ref-type="bibr" rid="bib3">Bär et al., 2016</xref>). LncRNAs were shown to regulate cardiac electrophysiological properties by altering the function of different ion channels. For example, the increased expression of <italic>lncKcna2as</italic> in heart failure reduced <italic>I</italic><sub>ks</sub> and prolonged action potential duration (APD) (<xref ref-type="bibr" rid="bib12">Long et al., 2017</xref>). <italic>LncMALAT1</italic> enhanced arrhythmia susceptibility by suppressing <italic>I</italic><sub>to</sub> and prolonging APD (<xref ref-type="bibr" rid="bib30">Zhu et al., 2018</xref>). In a previous study, we found that <italic>lncCCRR</italic> (cardiac conduction regulatory) interacts with connexin-43 interacting protein 85(CIP85) to promote connexin-43 membrane distribution and improve the impaired cardiac conduction of failing hearts (<xref ref-type="bibr" rid="bib29">Zhang et al., 2018</xref>). However, to date, it remains unknown whether and how lncRNA regulates sodium channel.</p><p><italic>LncDACH1</italic> is an intronic lncRNA located on the first intron of the <italic>DACH1</italic> gene (<xref ref-type="bibr" rid="bib4">Cai et al., 2019</xref>). We previously showed that <italic>lncDach1</italic> impairs cardiac function by promoting the degradation of sarco-endoplasmic reticulum <italic>Atp2a2</italic> (SERCA2a), and exacerbates cardiac ischemia injury by inhibiting Yes-associated protein 1 (YAP1) mediated proliferation of neonatal cardiomyocytes (<xref ref-type="bibr" rid="bib4">Cai et al., 2019</xref>; <xref ref-type="bibr" rid="bib5">Cai et al., 2020</xref>). While analyzing the interacting proteins of <italic>lncDach1</italic> identified by mass spectrometry, we found dystrophin that drove us to hypothesize that <italic>lncDach1</italic> may be a critical regulator of sodium channel Nav1.5.</p><p>Therefore, in this study, we explored whether <italic>lncDach1</italic> regulates Nav1.5 by interacting with dystrophin. We found that <italic>lncDach1</italic> inhibited the membrane trafficking of Nav1.5 by binding to dystrophin, which led to reduced sodium current and increased ventricular arrhythmia susceptibility. The study highlights a novel mechanism for the regulation of sodium channel trafficking, and reveals a potential therapeutic target for sodium channel dysfunction-related cardiac arrhythmias.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>LncDach1</italic> binds to dystrophin and reduces Nav1.5 membrane distribution in cardiomyocytes of <italic>lncDach1</italic> transgenic mice</title><p>We first validated the binding between <italic>lncDach1</italic> and dystrophin. The RNA pulldown plus immunoblot assay confirmed that <italic>lncDach1</italic> can successfully pulldown dystrophin (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). These data indicated that <italic>lncDach1</italic> does not interact with Nav1.5 directly. Consistently, the RNA immunoprecipitation (RIP) study showed that the antibody for dystrophin precipitated <italic>lncDach1</italic>, while the negative control IgG did not (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Conversely, <italic>lncDach1</italic> failed to pulldown Nav1.5, and anti-Nav1.5 did not precipitate <italic>lncDach1</italic> (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Binding of lncRNA-Dachshund homolog 1 (<italic>lncDach1</italic>) to dystrophin and the effects of cardiomyocyte-specific transgenic overexpression of <italic>lncDach1</italic> (<italic>lncDach1</italic>-TG) on the expression and function of sodium channel.</title><p>(<bold>A</bold>) Blotting of dystrophin pulled-down by <italic>lncDach1</italic>. (<bold>B</bold>) <italic>LncDach1</italic> precipitated by the antibody of dystrophin. N=4. *p&lt;0.05 vs IgG by one-way ANOVA, followed by Tukey’s post-hoc analysis. (<bold>C, D</bold>) The total, membrane and intracellular levels of dystrophin and Nav1.5 by Western blot. N-cadherin is the loading control for membrane extracts. N=10–11 for total protein; N=7–14 for membrane protein; N=8–14 for intracellular protein. *p&lt;0.05 vs wild-type (WT) group. p-values were determined by unpaired t-test. (<bold>E</bold>) Distribution of <italic>lncDach1</italic>, dystrophin, and Nav1.5 in isolated cardiomyocytes. (<bold>F</bold>) The mRNA levels of <italic>Dmd</italic> and <italic>Scn5a</italic>. N=8–11. (<bold>G</bold>) Peak <italic>I</italic><sub>Na</sub> currents, I-V curve and kinetics of <italic>I</italic><sub>Na.</sub> N=9–21 cells from three mice. *p&lt;0.05 vs WT group. (<bold>H</bold>) Conduction velocity of perfused hearts by optical mapping recordings. N=7. *p&lt;0.05 <italic>vs</italic> WT group. p-values were determined by unpaired t-test.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1">Figure 1B-D and F-H</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig1">Figure 1A</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig1-data2-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig1sdata3"><label>Figure 1—source data 3.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig1">Figure 1A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig1-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata4"><label>Figure 1—source data 4.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig1">Figure 1C</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig1-data4-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig1sdata5"><label>Figure 1—source data 5.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig1">Figure 1C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig1-data5-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata6"><label>Figure 1—source data 6.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig1">Figure 1D</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig1-data6-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig1sdata7"><label>Figure 1—source data 7.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig1">Figure 1D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig1-data7-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Examination of the potential interaction between lncRNA-Dachshund homolog 1 (<italic>lncDach1</italic>) and Nav1.5.</title><p>(<bold>A</bold>) Pulldown of Nav1.5 with sense and antisense sequences of <italic>lncDach1</italic>. (<bold>B</bold>) RNA immunoprecipitation of <italic>lncDach1</italic> with anti-Nav1.5 antibody. N=4.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig1-figsupp1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata2"><label>Figure 1—figure supplement 1—source data 2.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig1-figsupp1-data2-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata3"><label>Figure 1—figure supplement 1—source data 3.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig1-figsupp1-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata4"><label>Figure 1—figure supplement 1—source data 4.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig1-figsupp1-data4-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Fluorescence intensity of lncRNA-Dachshund homolog 1 (<italic>lncDach1</italic>), dystrophin, and Nav1.5 in isolated cardiomyocytes of <italic>lncDach1</italic>-TG mice.</title><p>(<bold>A, B</bold>) Membrane levels of dystrophin (dys) and Nav1.5. N=9 for dys. N=8 for Nav1.5. *p&lt;0.05 vs wild-type (WT) group. (<bold>C, D</bold>) Intracellular levels of dystrophin and Nav1.5. N=9. *p&lt;0.05 vs WT group. (<bold>E</bold>) Fluorescence in situ hybridization (FISH) images of <italic>LncDach1</italic>. N=10. *p&lt;0.05 vs WT group. p-values were determined by unpaired t-test.</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig1-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig1-figsupp2-v1.tif"/></fig></fig-group><p>We next explored the influence of <italic>lncDach1</italic> on the cellular distribution of dystrophin. The western blot data showed that the total protein of dystrophin did not change, while the membrane fraction was reduced, and the intracellular fraction was increased in the hearts of <italic>lncDach1</italic>-TG mice than wild-type (WT) controls (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Accordingly, the membrane and total protein levels of Nav1.5 were reduced, while intracellular Nav1.5 increased in the hearts of <italic>lncDach1</italic>-TG mice than WT controls (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). The reduced membrane distribution of dystrophin and Nav1.5 in the cardiomyocytes of <italic>lncDach1</italic>-Tg mice was further confirmed by immunofluorescent staining (<xref ref-type="fig" rid="fig1">Figure 1E</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). The mRNA levels of <italic>Dystrophin</italic> and <italic>Scn5a</italic> did not change (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). We then evaluated the functional change of the sodium channel. Consistent with the reduction of membrane Nav1.5, the peak <italic>I</italic><sub>Na</sub> was significantly decreased in the ventricular myocytes of <italic>lncDach1</italic>-TG mice than WT controls, while the kinetics of <italic>I</italic><sub>Na</sub> (activation, inactivation, and recovery) did not change (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). Meanwhile, the conduction velocity was slower in the hearts of <italic>lncDach1</italic>-TG than WT mice (<xref ref-type="fig" rid="fig1">Figure 1H</xref>).</p><p>We then applied <italic>lncDach1</italic> adenovirus to cultured neonatal cardiomyocytes to confirm the regulation of <italic>lncDach1</italic> on sodium channels in vitro. Infection of adenovirus carrying <italic>lncDach1</italic> significantly upregulated the level of <italic>lncDach1</italic> (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) and remarkably inhibited peak <italic>I</italic><sub>Na</sub> with no change in kinetics (<xref ref-type="fig" rid="fig2">Figure 2B and C</xref>). The western blot data showed that the total protein of dystrophin did not change, while the membrane fraction was reduced, and the intracellular fraction increased in neonatal cardiomyocytes with <italic>lncDach1</italic> overexpression (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Consistently, the membrane protein level and total protein level of Nav1.5 were reduced, while intracellular Nav1.5 increased in neonatal cardiomyocytes with <italic>lncDach1</italic> overexpression (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). The membrane distribution of dystrophin and Nav1.5 was remarkably reduced by overexpression of <italic>lncDach1</italic> as indicated by immunofluorescent staining (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). The mRNA levels of <italic>Dmd</italic> and <italic>Scn5a</italic> were not altered by <italic>lncDach1</italic> overexpression (<xref ref-type="fig" rid="fig2">Figure 2E</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Effects of lncRNA-Dachshund homolog 1 (<italic>lncDach1</italic>) overexpression on sodium channel expression and function in cultured neonatal cardiomyocytes.</title><p>(<bold>A</bold>) Verification of the expression of <italic>lncDach1</italic> after transfection of adenovirus carrying <italic>lncDach1</italic>. N=7–8 from three independent cultures. *p&lt;0.05 vs NC (negative control, empty plasmid). p-values were determined by unpaired t-test. (<bold>B, C</bold>) Peak <italic>I</italic><sub>Na</sub> currents, I-V curves and kinetics of <italic>I</italic><sub>Na.</sub> N=7–25 cells from three independent cultures. *p&lt;0.05 vs NC. (<bold>D</bold>) Distribution of Nav1.5 and dystrophin by immunofluorescent staining. (<bold>E</bold>) The mRNA levels of <italic>Dmd</italic> and <italic>Scn5a</italic>. N=8–10 from hree independent cultures.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2">Figure 2A–C and E</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Overexpression of <italic>lncDach1</italic>(oe-<italic>lncDach1</italic>) in cultured neonatal cardiomyocytes decreased membrane dystrophin and Nav1.5 expression.</title><p>(<bold>A</bold>) The total, membrane and intracellular levels of dystrophin by Western blot. N-cadherin is the loading control for membrane extracts. N=10 for total protein; N=6 for membrane protein; N=7 for intracellular protein. *p&lt;0.05 vs negative control (NC) group. p-values were determined by unpaired t-test. (<bold>B</bold>) The total, membrane and intracellular levels of Nav1.5 by Western blot. N-cadherin is the loading control for membrane extracts. N=5 for total protein; N=5 for membrane protein; N=9 for intracellular protein. *p&lt;0.05 vs wild-type (WT) group. p-values were determined by unpaired t-test.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A–B</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig2-figsupp1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata2"><label>Figure 2—figure supplement 1—source data 2.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig2-figsupp1-data2-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata3"><label>Figure 2—figure supplement 1—source data 3.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig2-figsupp1-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata4"><label>Figure 2—figure supplement 1—source data 4.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig2-figsupp1-data4-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata5"><label>Figure 2—figure supplement 1—source data 5.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig2-figsupp1-data5-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Fluorescence intensity of dystrophin and Nav1.5 in cultured neonatal cardiomyocyte overexpressing lncRNA-Dachshund homolog 1 (<italic>lncDach1</italic>).</title><p>(<bold>A, B</bold>) Membrane levels of dystrophin and Nav1.5. N=9. *p&lt;0.05 vs negative control (NC) group. (<bold>C, D</bold>) Intracellular levels of dystrophin and Nav1.5. N=9 for dys. N=12 for Nav1.5. *p&lt;0.05 vs NC group. P-values were determined by unpaired t-test.</p><p><supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig2-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig2-figsupp2-v1.tif"/></fig></fig-group></sec><sec id="s2-2"><title>Inhibition of <italic>lncDach1</italic> in cardiomyocytes increased membrane Nav1.5 distribution</title><p>We then employed <italic>lncDach1</italic> cardiomyocyte conditional knockout (<italic>lncDach1</italic>-cKO) mice to examine the regulation of <italic>lncDach1</italic> on dystrophin and Nav1.5. The western blot data showed that membrane distribution of dystrophin was increased in the hearts of <italic>lncDach1</italic>-cKO mice than WT controls, while the total dystrophin protein and <italic>Dystrophin</italic> mRNA did not change (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Consistently, the membrane and total level of Nav1.5 was increased in the hearts of <italic>lncDach1</italic>-cKO mice than WT controls, with no change in <italic>Scn5a</italic> mRNA (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). The change in dystrophin and Nav1.5 membrane distribution was further validated by immunofluorescent staining (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Meanwhile, the peak <italic>I</italic><sub>Na</sub> was larger in cardiomyocytes of <italic>lncDach1</italic>-cKO mice than WT controls, while the kinetics of <italic>I</italic><sub>Na</sub> (activation, inactivation, and recovery) did not change (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Consistent with the increase of peak <italic>I</italic><sub>Na</sub>, the conduction velocity in the hearts of <italic>lncDach1</italic>-cKO mice was faster than WT controls (<xref ref-type="fig" rid="fig3">Figure 3E</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Conditional knockout of negative control (<italic>lncDach1)</italic> (<italic>lncDach1</italic>-cKO) in cardiomyocytes increased peak sodium current, membrane Nav1.5 expression.</title><p>(<bold>A</bold>) The total, membrane and intracellular levels of dystrophin by Western blot and <italic>Dmd</italic> mRNA by qRT-PCR. N-cadherin is the loading control for membrane extracts. N=10 for total protein; N=10 for membrane protein; N=15 for intracellular protein. *p&lt;0.05 vs ild-type (WT) group. p-values were determined by unpaired t-test. (<bold>B</bold>) The total, membrane and intracellular levels of Nav1.5 by Western blot and <italic>Scn5a</italic> mRNA by qRT-PCR. N-cadherin is the loading control for membrane extracts. N=10 for total protein; N=8 for membrane protein; N=8 for intracellular protein. *p&lt;0.05 vs WT group. p-values were determined by unpaired t-test. (<bold>C</bold>) Distribution of <italic>lncDach1</italic>, dystrophin, and Nav1.5 in isolated cardiomyocytes. (<bold>D</bold>) Peak <italic>I</italic><sub>Na</sub> currents, I-V curve, and kinetics of <italic>I</italic><sub>Na.</sub> N=7–21 cells; N=3 mice of WT; N=4 mice of <italic>LncDach1</italic> (cKO). *p&lt;0.05 vs WT group. (<bold>E</bold>) Conduction velocity of perfused hearts by optical mapping recordings. N=7 and 5. *p&lt;0.05 vs WT group. p-values were determined by unpaired t-test.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig3">Figure 3A-B and D-E</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig3-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig3">Figure 3A</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig3-data2-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig3sdata3"><label>Figure 3—source data 3.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig3">Figure 3A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig3-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata4"><label>Figure 3—source data 4.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig3">Figure 3B</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig3-data4-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig3sdata5"><label>Figure 3—source data 5.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig3">Figure 3B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig3-data5-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Fluorescence intensity of lncRNA-Dachshund homolog 1 (<italic>lncDach1</italic>), dystrophin, and Nav1.5 in isolated cardiomyocytes of <italic>lncDach1</italic>-cKO mice.</title><p>(<bold>A, B</bold>) Membrane levels of dystrophin (dys) and Nav1.5. N=12 for dys. N=8 for Nav1.5. *p&lt;0.05 vs wild-type (WT) group. (<bold>C, D</bold>) Distribution of intracellular levels of dystrophin and Nav1.5. N=12. *p&lt;0.05 vs WT group. (<bold>E</bold>) Fluorescence in situ hybridization (FISH) images of <italic>LncDach1</italic> expression. N=8. *p&lt;0.05 vs WT group. p-values were determined by unpaired t-test.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig3-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig3-figsupp1-v1.tif"/></fig></fig-group><p>We further confirmed the effects of <italic>lncDach1</italic> knockdown with its shRNA on sodium channels in cultured neonatal cardiomyocytes in vitro. Infection of adenovirus carrying shRNA for <italic>lncDach1</italic> significantly reduced the level of <italic>lncDach1</italic> (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). The patch-clamp recordings showed that the knockdown of <italic>lncDach1</italic> significantly increased the current density of peak <italic>I</italic><sub>Na</sub> with no change in channel kinetics (<xref ref-type="fig" rid="fig4">Figure 4B and C</xref>). The western blot data showed that the total protein of dystrophin did not change, while the membrane fraction was increased, and the intracellular fraction was reduced after <italic>lncDach1</italic> knockdown (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). Consistently, the membrane and total protein levels of Nav1.5 were increased, while intracellular Nav1.5 reduced after <italic>lncDach1</italic> knockdown (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). Membrane distribution of dystrophin and Nav1.5 were both increased after the knockdown of <italic>lncDach1</italic> as indicated by immunofluorescent staining (<xref ref-type="fig" rid="fig4">Figure 4D</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). The mRNA levels of <italic>Dmd</italic> and <italic>Scn5a</italic> were not altered by <italic>lncDach1</italic> knockdown (<xref ref-type="fig" rid="fig4">Figure 4E</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Effects of lncRNA-Dachshund homolog 1 (<italic>lncDach1</italic>) knockdown on sodium channel expression and function in cultured neonatal cardiomyocytes.</title><p>(<bold>A</bold>) Verification of the expression of <italic>lncDach1</italic> after infection of adenovirus carrying <italic>lncDach1</italic> shRNA. N=15 from three independent cultures. *p&lt;0.05 vs NC (negative control, empty plasmids). p-values were determined by unpaired t-test. (<bold>B, C</bold>) Peak <italic>I</italic><sub>Na</sub> currents, I-V curve and kinetics of <italic>I</italic><sub>Na.</sub> N=8–15 from three independent cultures. *p&lt;0.05 vs NC. (<bold>D</bold>) Distribution of Nav1.5 and dystrophin by immunofluorescent staining. (<bold>E</bold>) The mRNA levels of <italic>Dmd</italic> and <italic>Scn5a</italic>. N=11–15 from three independent cultures.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4">Figure 4A–C and E</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Effects of lncRNA-Dachshund homolog 1 (<italic>lncDach1</italic>) knockdown with shRNA on the protein expression of dystrophin and Nav1.5 expression in cultured neonatal cardiomyocytes.</title><p>(<bold>A</bold>) The total, membrane and intracellular levels of dystrophin by Western blot. N-cadherin is the loading control for membrane extracts. N=10 for total protein; N=7 for membrane protein; N=5 for intracellular protein. *p&lt;0.05 vs NC group. p-values were determined by unpaired t-test. (<bold>B</bold>) The total, membrane and intracellular levels of Nav1.5 by Western blot. N-cadherin is the loading control for membrane extracts. N=15 for total protein; N=6 for membrane protein; N=11 for intracellular protein. *p&lt;0.05 vs wild-type (WT) group. p-values were determined by unpaired t-test. Dys, dystrophin; NC, negative control; sh-<italic>lncDach1</italic>, shRNA for <italic>lncDach1</italic>.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A–B</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig4-figsupp1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata2"><label>Figure 4—figure supplement 1—source data 2.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig4-figsupp1-data2-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata3"><label>Figure 4—figure supplement 1—source data 3.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig4-figsupp1-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata4"><label>Figure 4—figure supplement 1—source data 4.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig4-figsupp1-data4-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata5"><label>Figure 4—figure supplement 1—source data 5.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig4-figsupp1-data5-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Fluorescence intensity of dystrophin and Nav1.5 in cultured neonatal cardiomyocytes after knocking down of lncRNA-Dachshund homolog 1 (<italic>lncDach1</italic>).</title><p>(<bold>A, B</bold>) Distribution of membrane levels of dystrophin and Nav1.5. N=11 for dys. N=8 for Nav1.5.*p&lt;0.05 vs negative control (NC) group. (<bold>C, D</bold>) Distribution of intracellular levels of dystrophin and Nav1.5. N=12 for dys. N=9 for Nav1.5.*p&lt;0.05 vs NC group. p-values were determined by unpaired t-test.</p><p><supplementary-material id="fig4s2sdata1"><label>Figure 4—figure supplement 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig4-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig4-figsupp2-v1.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>The mRNA expression of <italic>Klhl1</italic>, <italic>Bora</italic>, <italic>Mzt1</italic>, <italic>Dis3,</italic> and <italic>Dach1</italic> in the cardiac tissue of lncRNA-Dachshund homolog 1 (<italic>lncDach1</italic>) knockout (<bold>A</bold>) and transgenic overexpression (<bold>B</bold>) mice.</title><p>N=7–12. *p&lt;0.05 vs wild-type (WT). Data are expressed as mean ± SEM. Wt, wild-type litter mates; <italic>lncDach1</italic>(Tg), <italic>lncDach1</italic> cardiac transgenic overexpression; <italic>lncDach1</italic>(CKO), <italic>lncDach1</italic> cardiomyocyte conditional knockout.</p><p><supplementary-material id="fig4s3sdata1"><label>Figure 4—figure supplement 3—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig4-figsupp3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig4-figsupp3-v1.tif"/></fig></fig-group><p>In addition, neither knockout nor transgenic overexpression of <italic>lncDach1</italic> changed the expression of <italic>Dach1</italic> and its neighbor genes (<italic>Klhl1, Bora, Mzt1, Dis3</italic>) (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>).</p></sec><sec id="s2-3"><title>Transgenic overexpression of <italic>lncDach1</italic> is arrhythmogenic in mice</title><p>We next evaluated whether the inhibition of Nav1.5 by <italic>lncDach1</italic> is arrhythmogenic in <italic>lncDach1</italic>-TG mice. Electrical pacing technique was employed to evaluate the arrhythmia susceptibility of intact hearts in vivo and isolated hearts ex vivo. The in vivo study showed that programmed pacing induced more ventricular arrhythmia in <italic>lncDach1</italic>-TG mice that WT controls. Both induction rate and episodes of ventricular arrhythmia were higher in <italic>lncDach1</italic>-TG mice (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Consistent with the results of in vivo., the ex vivo electrical pacing study demonstrated that ventricular arrhythmia was more frequently occurred in <italic>lncDach1</italic>-TG mice (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). The optical mapping study revealed that there are more breaking points in the perfused heart of <italic>lncDach1</italic>-TG mice than WT controls (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>). Conversely, no ventricular arrhythmia was induced in the hearts of <italic>lncDach1</italic>-cKO mice (<xref ref-type="fig" rid="fig5">Figure 5E</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Increased arrhythmia susceptibility in lncRNA-Dachshund homolog 1 (<italic>lncDach1</italic>)-TG mice.</title><p>(<bold>A</bold>) Ventricular fibrillation (VF) induced by S1S2 pacing in intact mice. The red lines in the ECG traces indicate VF duration. N=10–16. SN: sinus rhythm (<bold>B</bold>) VF induced by S1S1 pacing of perfused hearts. (<bold>C</bold>) Break points during VT of WT and <italic>lncDach1</italic>-TG mice by optical mapping. Consecutive phase maps sampled at 10 ms interval during VF from WT and TG mice. Phase singularities (wavebreaks) are indicated by phase maps. Upper panels showed a corresponding optical recording of VF at asterisk site. N=8. (<bold>D</bold>) The number of phase singularities and dominant frequency of WT and TG mice. (<bold>E</bold>) VF induced by S1S1 pacing in perfused hearts. N=5–7 mice.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5">Figure 5A-B and D-E</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig5-v1.tif"/></fig></sec><sec id="s2-4"><title>The conservative fragment of <italic>lncDach1</italic> reduced peak sodium current and promoted ventricular arrhythmia</title><p>The sequence blasting data showed that the fragment of <italic>lncDach1</italic> from 835 to 2085 nts is conservative between humans and mouse. We then cut <italic>lncDach1</italic> into different fragments (<xref ref-type="fig" rid="fig6">Figure 6A</xref>) to evaluate the sequence that is responsible for the binding with dystrophin. The data showed that only fragments containing the conserved sequence, fragments a and b, can pulldown dystrophin, indicating that the conserved sequence may be the functional region of <italic>lncDach1</italic> (<xref ref-type="fig" rid="fig6">Figure 6A</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>The conserved fragment of lncRNA-Dachshund homolog 1 (<italic>lncDach1</italic>) (cF-<italic>lncDach1</italic>) inhibited sodium channel function in mice.</title><p>(<bold>A</bold>) Pulldown of dystrophin by fragments of <italic>lncDach1</italic> as indicated. (<bold>B</bold>) Verification of the expression of cF-<italic>lncDach1</italic> after injection of adeno-virus carrying cF-<italic>lncDach1</italic>. N=5. *p&lt;0.05 vs NC (negative control, Adeno-virus carrying empty plasmid). P-values were determined by unpaired t-test. (<bold>C</bold>) The total, membrane and intracellular levels of dystrophin and Nav1.5 by Western blot. N-cadherin is the loading control for membrane extracts. N=11–12 for total protein; N=10 for membrane protein; N=5–11 for intracellular protein. *p&lt;0.05 vs NC group. P-values were determined by unpaired t-test. (<bold>D</bold>) Distribution of dystrophin and Nav1.5 in isolated cardiomyocytes. (<bold>E</bold>) Representative traces and I-V curve of peak <italic>I</italic><sub>Na</sub> currents. N=20–29 cells; N=3 mice of NC; N=4 mice of cF-<italic>lncDach1</italic>. *p&lt;0.05 <italic>vs</italic> NC group. (<bold>F</bold>) Conduction velocity of perfused hearts by optical mapping recordings. N=9–10. *p&lt;0.05 vs NC group. p-values were determined by unpaired t-test. (<bold>G</bold>) Break points during ventricular tachycardia (VT) by optical mapping. (<bold>H</bold>) Ventricular fibrillation (VF) induced by S1S2 pacing in intact mice. The induction rate, average episodes and duration of VF were determined from ECG recordings. The red lines in the ECG traces indicate VF duration. N=11 for NC; N=18 for cF-<italic>lncDach1</italic>. *p&lt;0.05 vs NC group.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6">Figure 6B–C, E–F and H</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig6-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig6">Figure 6A</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig6-data2-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig6sdata3"><label>Figure 6—source data 3.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig6">Figure 6A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig6-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata4"><label>Figure 6—source data 4.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig6">Figure 6C</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig6-data4-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig6sdata5"><label>Figure 6—source data 5.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig6">Figure 6C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig6-data5-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Fluorescence intensity of dystrophin and Nav1.5 in isolated cardiomyocytes overexpressing cF-<italic>lncDach1</italic>.</title><p>(<bold>A, B</bold>) Membrane levels of dystrophin (dys) and Nav1.5. N=9 for dys. N=7 for Nav1.5. *p&lt;0.05 vs negative control (NC) group. (<bold>C, D</bold>) Intracellular levels of dystrophin and Nav1.5. N=6 for dys. N=7 for Nav1.5. *p&lt;0.05 vs NC group. p-values were determined by unpaired t-test.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig6-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>The conserved fragment of <italic>lncDach1</italic>(cF-<italic>lncDach1</italic>) inhibited sodium channel function in mice.</title><p>(<bold>A</bold>) The mRNA levels of <italic>Scn5a</italic> and <italic>Dmd</italic>. N=4–5. (<bold>B</bold>) Kinetics of <italic>I</italic><sub>Na.</sub> N=6–29 cells; N=3 mice of NC; N=4 mice of cF-<italic>lncDach1</italic>.</p><p><supplementary-material id="fig6s2sdata1"><label>Figure 6—figure supplement 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig6-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig6-figsupp2-v1.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title>Effects of cF-<italic>lncDach1</italic> overexpression on sodium channel expression and function in cultured neonatal cardiomyocytes.</title><p>(<bold>A</bold>) Verification of the expression of cF-<italic>lncDach1</italic> after transfection of adenovirus carrying cF-<italic>lncDach1</italic>. N=8 from three independent cultures. *p&lt;0.05 vs NC (negative control, empty plasmid). p-values were determined by unpaired t-test. (<bold>B</bold>) Peak <italic>I</italic><sub>Na</sub> currents, I-V curves and kinetics of <italic>I</italic><sub>Na.</sub> N=8–15 cells from three independent cultures. *p&lt;0.05 vs NC, p-values were determined by unpaired t-test. (<bold>C</bold>) Distribution of Nav1.5 and dystrophin by immunofluorescent staining. (<bold>D</bold>) The mRNA levels of <italic>Dmd</italic> and <italic>Scn5a</italic>. N=8–12 from three independent cultures.</p><p><supplementary-material id="fig6s3sdata1"><label>Figure 6—figure supplement 3—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3A–B and D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig6-figsupp3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig6-figsupp3-v1.tif"/></fig><fig id="fig6s4" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 4.</label><caption><title>Fluorescence intensity of dystrophin and Nav1.5 in cultured neonatal cardiomyocytes overexpressing cF-<italic>lncDach1</italic>.</title><p>(<bold>A, B</bold>) Membrane levels of dystrophin and Nav1.5. N=10 for dys. N=11 for Nav1.5. *p&lt;0.05 vs negative control (NC) group. (<bold>C, D</bold>) Intracellular levels of dystrophin and Nav1.5. N=7 for dys. N=6 for Nav1.5.*p&lt;0.05 v s NC group. p-values were determined by unpaired t-test.</p><p><supplementary-material id="fig6s4sdata1"><label>Figure 6—figure supplement 4—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6s4">Figure 6—figure supplement 4</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig6-figsupp4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig6-figsupp4-v1.tif"/></fig><fig id="fig6s5" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 5.</label><caption><title>Overexpression of cF-<italic>lncDach1</italic>(oe-cF-<italic>lncDach1</italic>) in cultured neonatal cardiomyocytes decreased membrane dystrophin and Nav1.5 expression.</title><p>(<bold>A</bold>) The total, membrane and intracellular levels of dystrophin by Western blot. N-cadherin is the loading control for membrane extracts. N=5 for total protein; N=8 for membrane protein; N=6 for intracellular protein. *p&lt;0.05 vs negative control (NC) group. p-values were determined by unpaired t-test. (<bold>B</bold>) The total, membrane and intracellular levels of Nav1.5 by Western blot. N-cadherin is the loading control for membrane extracts. N=8 for total protein; N=6 for membrane protein; N=11 for intracellular protein. *p&lt;0.05 vs wild-type (WT) group. p-values were determined by unpaired t-test.</p><p><supplementary-material id="fig6s5sdata1"><label>Figure 6—figure supplement 5—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6s5">Figure 6—figure supplement 5A–B</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig6-figsupp5-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6s5sdata2"><label>Figure 6—figure supplement 5—source data 2.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig6s5">Figure 6—figure supplement 5A</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig6-figsupp5-data2-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig6s5sdata3"><label>Figure 6—figure supplement 5—source data 3.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig6s5">Figure 6—figure supplement 5A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig6-figsupp5-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6s5sdata4"><label>Figure 6—figure supplement 5—source data 4.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig6s5">Figure 6—figure supplement 5B</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig6-figsupp5-data4-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig6s5sdata5"><label>Figure 6—figure supplement 5—source data 5.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig6s5">Figure 6—figure supplement 5B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig6-figsupp5-data5-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig6-figsupp5-v1.tif"/></fig><fig id="fig6s6" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 6.</label><caption><title>Conservation of <italic>lncDACH1</italic>.</title><p>(<bold>A</bold>) UCSC snapshot of lncRNA-Dachshund homolog 1 (<italic>lncDACH1</italic>) (<bold>B</bold>) Conservation of <italic>lncDACH1</italic> between mice and other species.</p><p><supplementary-material id="fig6s6sdata1"><label>Figure 6—figure supplement 6—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6s6">Figure 6—figure supplement 6B</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig6-figsupp6-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig6-figsupp6-v1.tif"/></fig></fig-group><p>We then examined the influence of the conserved sequence from 835 to 2085 nts (conserved fragment of <italic>lncDach1</italic>, cF- <italic>lncDach1</italic>) on the cardiac sodium channel. The adenovirus carrying cF- <italic>lncDach1</italic> was constructed and administered to mice. The successful overexpression of cF- <italic>lncDach1</italic> was validated by qRT-PCR (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Administration of cF- <italic>lncDach1</italic> reduced the membrane distribution, and increased intracellular expression of both dystrophin and Nav1.5 as indicated by western blot and immunofluorescent data (<xref ref-type="fig" rid="fig6">Figure 6C, D</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). The mRNA levels of <italic>Dmd</italic> and <italic>Scn5a</italic> were not affected by cF- <italic>lncDach1</italic> (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A</xref>). Overexpression of cF- <italic>lncDach1</italic> reduced peak <italic>I</italic><sub>Na</sub> currents (<xref ref-type="fig" rid="fig6">Figure 6E</xref>), and produced no influence on channel kinetics (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2B</xref>). The optical mapping data showed that administration of cF- <italic>lncDach1</italic> reduced conduction velocity and increased breakpoints of ventricular arrhythmias (<xref ref-type="fig" rid="fig6">Figure 6F and G</xref>). The induction rate and episodes of ventricular tachycardia (VT) were higher in the cF- <italic>lncDach1</italic> group than in controls (<xref ref-type="fig" rid="fig6">Figure 6H</xref>).</p><p>In cultured neonatal cardiomyocytes, overexpression of cF- <italic>lncDach1</italic> reduced peak <italic>I</italic><sub>Na</sub> with no change in kinetics, inhibited membrane distribution of dystrophin and Nav1.5, and produced no influence on the mRNA levels of <italic>Dmd</italic> and <italic>Scn5a</italic> (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplements 3</xref> and <xref ref-type="fig" rid="fig6s4">4</xref>). The western blot data showed that the total protein of dystrophin did not change, while the membrane fraction was reduced, and the intracellular fraction increased after overexpression of cF- <italic>lncDach1</italic> (<xref ref-type="fig" rid="fig6s5">Figure 6—figure supplement 5A</xref>). Consistently, the membrane and total protein levels of Nav1.5 were reduced, while intracellular Nav1.5 increased after overexpression of cF- <italic>lncDach1</italic> (<xref ref-type="fig" rid="fig6s5">Figure 6—figure supplement 5B</xref>).</p><p>We also blasted the <italic>lncDACH1</italic> in different species and found that <italic>lncDACH1</italic> is conserved among sheep, pigs, dogs, rats, humans and mouse (<xref ref-type="fig" rid="fig6s6">Figure 6—figure supplement 6</xref>).</p></sec><sec id="s2-5"><title>Activation of dystrophin transcription by the dCas9-SAM system prevented the reduction of sodium current in <italic>lncDach1</italic> transgenic mice</title><p>As <italic>lncDach1</italic> reduced Nav1.5 membrane targeting by interacting with dystrophin, we reasoned that overexpression of dystrophin may rescue the inhibition of Nav1.5 by <italic>lncDach1</italic>. To test this notion, we constructed the AAV9 virus carrying dCas9-SAM system that can activate <italic>Dmd</italic> transcription (AAV9-Dys-Act) to perform rescuing experiments on <italic>lncDach1</italic>-TG mice (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). Tail vein injection of the AAV9-Dys-Act virus significantly increased the mRNA level of <italic>Dystrophin</italic> in the hearts of both WT and <italic>lncDach1</italic>-TG mice (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). The western blot data showed that overexpression of dystrophin with AAV9-Dys-Act virus increased both total and membrane protein expression of dystrophin, and rescued the reduction of dystrophin expression in <italic>lncDach1</italic>-TG mice (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). The mRNA level of <italic>Scn5a</italic> was not influenced by AAV9-Dys-Act virus (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). Strikingly, AAV9-Dys-Act virus administration restored the total and membrane expression of Nav1.5 in <italic>lncDach1</italic>-TG mice (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). In addition, AAV9-Dys-Act virus injection rescued the reduction of peak <italic>I</italic><sub>Na</sub> current in <italic>lncDach1</italic>-TG mice (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). The kinetics of <italic>I</italic><sub>Na</sub> current did not change among groups (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). Activation of dystrophin transcription with AAV9-Dys-Act virus restored the conduction velocity in <italic>lncDach1</italic>-TG mice (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). Both in vivo and ex vivo data indicated that activation of dystrophin transcription reduced the susceptibility to ventricular arrhythmia of <italic>lncDach1</italic>-TG mice (<xref ref-type="fig" rid="fig7">Figure 7E and F</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Activation of dystrophin transcription by adeno-associated virus 9 (AAV9) virus carrying dCas9-SAM system (AAV9-Dys-Act) rescued the remodeling of sodium channel in <italic>lncDach1</italic>-TG mice.</title><p>(<bold>A</bold>) The mRNA level of <italic>Dmd</italic> by real-time PCR (N=12–17) and the total, membrane and intracellular protein levels of dystrophin by western blot. N-cadherin is the loading control for membrane extracts. N=7 for total protein; N=8 for membrane protein; N=8 for intracellular protein. *p&lt;0.05 vs egative control (NC) group. <bold><sup>#</sup></bold>p&lt;0.05 vs TG group. NC, AAV9 virus carrying dCas9-SAM system with control sgRNA; Dys, AAV9 virus carrying dCas9-SAM system with sgRNA targeting dystrophin promoter. (<bold>B</bold>) The mRNA level of <italic>Scn5a</italic> by real-time PCR (N=10–12) and the total, membrane and intracellular protein levels of Nav1.5 by western blot. N-cadherin is the loading control for membrane extracts. N=10 for total protein; N=5 for membrane protein; N=6 for intracellular protein. *p&lt;0.05 vs NC group. <bold><sup>#</sup></bold>p&lt;0.05 vs TG group. (<bold>C</bold>) Representative traces, I-V curves and kinetics of peak <italic>I</italic><sub>Na</sub> currents. N=7–20 cells; N=3 mice of WT + NC; N=3 mice of WT + Dys; N=3 mice of TG + NC; N=4 mice of TG + Dys. *p&lt;0.05 vs NC group. <bold><sup>#</sup></bold>p&lt;0.05 vs TG group. (<bold>D</bold>) Conduction velocity of perfused hearts by optical mapping recordings. N=6–9. *p&lt;0.05 vs NC group. <bold><sup>#</sup></bold>p&lt;0.05 vs TG group. p-values were determined by unpaired t-test. (<bold>E</bold>) Ventricular fibrillation (VF) induced by S1S1 pacing in perfused hearts. N=7–10. (<bold>F</bold>) VF induced by S1S2 pacing in intact mice. N=10–13. The data are analyzed by one-way ANOVA followed by Tukey’s post-hoc analysis.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig7">Figure 7</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig7-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig7sdata2"><label>Figure 7—source data 2.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig7">Figure 7A</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig7-data2-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig7sdata3"><label>Figure 7—source data 3.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig7">Figure 7A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig7-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig7sdata4"><label>Figure 7—source data 4.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig7">Figure 7B</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig7-data4-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig7sdata5"><label>Figure 7—source data 5.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig7">Figure 7B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig7-data5-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Schematic model for the construction of adeno-associated virus 9 (AAV9) virus carrying the dCas9-SAM system (<bold>A</bold>) to activate the transcription of dystrophin and tail-vein injection to mice (<bold>B</bold>).</title><p>VP64, VP64 transactivator; dCas9, deactivated CRISPR associated protein 9 nuclease. TSS, transcriptional start point.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig7-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-6"><title>Hadhb binds to <italic>lncDach1</italic> and promotes its decay</title><p>Reduced Nav1.5 expression and reduction of peak <italic>I</italic><sub>Na</sub> in heart failure have been reported by multiple studies (<xref ref-type="bibr" rid="bib2">Baba et al., 2005</xref>; <xref ref-type="bibr" rid="bib25">Valdivia et al., 2005</xref>; <xref ref-type="bibr" rid="bib27">Xi et al., 2009</xref>; <xref ref-type="bibr" rid="bib6">Dybkova et al., 2018</xref>). We therefore evaluated the contribution of <italic>lncDach1</italic> on sodium channel remodeling in transaortic constriction (TAC) induced heart failure model in mice. We found that <italic>lncDach1</italic> was increased in failing hearts than sham controls (<xref ref-type="fig" rid="fig8">Figure 8A</xref>). Although <italic>lncDach1</italic> was upregulated in failing hearts, the mRNA of its host gene <italic>Dach1</italic> did not change (<xref ref-type="fig" rid="fig8">Figure 8B</xref>). This finding excluded the transcription-related mechanism of <italic>lncDach1</italic> upregulation during heart failure. By analyzing the RNA Pulldown plus Mass Spectrometry data, we identified three potential interacting proteins of <italic>lncDach1</italic> that have been shown to regulate RNA stability. They are <italic>Anp32a</italic> (acidic leucine-rich nuclear phosphoprotein 32 A), <italic>Eif4a1</italic> (eukaryotic initiation factor 4A1), and <italic>Hadhb</italic> (hydroxyacyl-CoA dehydrogenase subunit beta). We therefore speculated that it may be the change of RNA stability that renders to the expression change of <italic>lncDach1</italic>. We then tested whether these proteins can affect <italic>lncDach1</italic> level by knocking down their expression with siRNA. The data showed that the knockdown of <italic>Hadhb</italic> increased the expression of <italic>lncDach1</italic>, while knockdown of <italic>Anp32a</italic> and <italic>Eif4a1</italic> produced no influence (<xref ref-type="fig" rid="fig8">Figure 8C</xref>). The influence of <italic>Hadhb</italic> on <italic>lncDach1</italic> stability was further validated by the fact that the knockdown of <italic>Hadhb</italic> increased the decaying half-life of <italic>lncDach1</italic> (<xref ref-type="fig" rid="fig8">Figure 8D</xref>). Furthermore, the sense sequence of <italic>lncDach1</italic> successfully pulled down hadhb, and the antibody of hadhb precipitated <italic>lncDach1</italic> (<xref ref-type="fig" rid="fig8">Figure 8E</xref>). Additionally, the protein level of hadhb was reduced in mouse failing hearts (<xref ref-type="fig" rid="fig8">Figure 8F</xref>), which is inversely correlated to the upregulation of <italic>lncDach1</italic>. The siRNA for <italic>Hadhb</italic> reduced the expression of Nav1.5 (<xref ref-type="fig" rid="fig8">Figure 8G</xref>). These data indicated that <italic>Hadhb</italic> is an upstream regulator of <italic>lncDach1</italic> which determines the stability of <italic>lncDach1</italic>.</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Hadhb binds to lncRNA-Dachshund homolog 1 (<italic>lncDach1</italic>) and promotes its decay.</title><p>(<bold>A</bold>) The expression level of <italic>lncDach1</italic> in the hearts of transaortic constriction (TAC) mice. N=5–8. *p&lt;0.05 by unpaired t-test. (<bold>B</bold>) The mRNA level of <italic>Dach1</italic> in the hearts of TAC mice. N=12–14. (<bold>C</bold>) Effects of siRNAs for <italic>Anp32a</italic>, <italic>Eif4a1,</italic> and <italic>Hadhb</italic> on the expression of <italic>lncDach1</italic>. N=5–12 from three independent cultures. * p&lt;0.05 by unpaired t-test. (<bold>D</bold>) The effects of <italic>Hadhb</italic> siRNA on the decay of <italic>lncDach1</italic>. N=6–15 from three independent cultures. (<bold>E</bold>) Blotting of hadhb pulled-down by <italic>lncDach1</italic>, and precipitation of <italic>lncDach1</italic> by anti-hadhb antibody. N=4. *p&lt;0.05 vs IgG by one-way ANOVA followed by Tukey’s post-hoc analysis. (<bold>F</bold>) The effects of heart failure on the protein expression of hadhb. N=9. *p&lt;0.05 vs sham group. p-values were determined by unpaired t-test. (<bold>G</bold>) The effects of <italic>Hadhb</italic> siRNA on the protein expression of Nav1.5, N=6. *p&lt;0.05 vs negative control (NC) group. p-values were determined by unpaired t-test. (<bold>H</bold>) <italic>LncDACH1</italic> inhibits Nav1.5 in human induced pluripotent stem cells (iPS) differentiated cardiomyocytes. (<bold>I</bold>) Schematic summary of the signaling pathway of <italic>lncDACH1</italic> and arrhythmia.</p><p><supplementary-material id="fig8sdata1"><label>Figure 8—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8">Figure 8A–G</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig8-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8sdata2"><label>Figure 8—source data 2.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig8">Figure 8E</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig8-data2-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig8sdata3"><label>Figure 8—source data 3.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig8">Figure 8E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig8-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig8sdata4"><label>Figure 8—source data 4.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig8">Figure 8F</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig8-data4-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig8sdata5"><label>Figure 8—source data 5.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig8">Figure 8F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig8-data5-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig8sdata6"><label>Figure 8—source data 6.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig8">Figure 8G</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig8-data6-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig8sdata7"><label>Figure 8—source data 7.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig8">Figure 8G</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig8-data7-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig8-v1.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>Fluorescence intensity of Nav1.5 in human induced pluripotent stem cells (iPS) differentiated cardiomyocytes overexpressing cF-<italic>lncDACH1</italic>.</title><p>(<bold>A</bold>) Membrane levels of Nav1.5. N=8 for Nav1.5. *p&lt;0.05 vs negative control (NC) group. (<bold>B</bold>) Intracellular levels of Nav1.5. N=10 for Nav1.5.*p&lt;0.05 vs NC group. p-values were determined by unpaired t-test.</p><p><supplementary-material id="fig8s1sdata1"><label>Figure 8—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig8-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig8-figsupp1-v1.tif"/></fig><fig id="fig8s2" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 2.</label><caption><title>Effects of cF-<italic>lncDACH1</italic> overexpression on sodium current and Vmax of APD in human induced pluripotent stem cells (hiPS)-CMs.</title><p>(<bold>A, B</bold>) Peak <italic>I</italic><sub>Na</sub> currents and I-V curve of <italic>I</italic><sub>Na.</sub> N=11–12 from three independent cultures. *p&lt;0.05 vs negative control (NC). (<bold>C, D</bold>) Rising phase diagram of action potential and V<sub>max</sub> of ascending branch of action potential phase 0, N=9. *p&lt;0.05 vs NC.</p><p><supplementary-material id="fig8s2sdata1"><label>Figure 8—figure supplement 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8s2">Figure 8—figure supplement 2B, D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89690-fig8-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig8-figsupp2-v1.tif"/></fig><fig id="fig8s3" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 3.</label><caption><title>Ubiquitination of Nav1.5 in the Primary cardiomyocytes of lncRNA-Dachshund homolog 1 (<italic>lncDach1</italic>) transgenic overexpression and knockout.</title><p>(<bold>A</bold>) The ubiquitination of Nav1.5 of overexpression of <italic>lncDach1</italic>. (<bold>B</bold>) The ubiquitination of Nav1.5 of Knockdown of <italic>lncDach1</italic>.</p><p><supplementary-material id="fig8s3sdata1"><label>Figure 8—figure supplement 3—source data 1.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig8s3">Figure 8—figure supplement 3A</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig8-figsupp3-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig8s3sdata2"><label>Figure 8—figure supplement 3—source data 2.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig8s3">Figure 8—figure supplement 3A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig8-figsupp3-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig8s3sdata3"><label>Figure 8—figure supplement 3—source data 3.</label><caption><title>Uncropped and labeled gels for <xref ref-type="fig" rid="fig8s3">Figure 8—figure supplement 3B</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-89690-fig8-figsupp3-data3-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig8s3sdata4"><label>Figure 8—figure supplement 3—source data 4.</label><caption><title>Raw unedited gels for <xref ref-type="fig" rid="fig8s3">Figure 8—figure supplement 3B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89690-fig8-figsupp3-data4-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89690-fig8-figsupp3-v1.tif"/></fig></fig-group><p>We lastly evaluated the human conserved sequence of <italic>lncDACH1</italic> (hcF- <italic>lncDACH1</italic>) on Nav1.5 distribution of human iPS-induced cardiomyocytes. We found that overexpression of hcF- <italic>lncDACH1</italic> reduced the membrane distribution of Nav1.5 (<xref ref-type="fig" rid="fig8">Figure 8H</xref>, <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>). To confirm the arrhythmogenic effects of hcF- <italic>lncDACH1</italic> in the hiPSC-CM model, we overexpressed hcF- <italic>lncDACH1</italic>. We found that overexpression of hcF- <italic>lncDACH1</italic> significantly inhibited sodium current and the Vmax of APD upstroke (<xref ref-type="fig" rid="fig8s2">Figure 8—figure supplement 2</xref>). These data indicate the arrhythmogenic effects of hcF- <italic>lncDACH1</italic>, and imply that knockdown of hcF- <italic>lncDACH1</italic> may reduce the susceptibility of arrhythmia.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we discovered that <italic>lncDACH1</italic> is a critical regulator of the sodium channel in the heart. <italic>lncDACH1</italic> binds to dystrophin and thus inhibits membrane trafficking of Nav1.5, which leads to the reduction of peak sodium current and impairment of cardiac conduction. Therefore, upregulation of <italic>lncDACH1</italic> increased the susceptibility to ventricular arrhythmia (<xref ref-type="fig" rid="fig8">Figure 8I</xref>).</p><p>LncRNAs have been established to be critical regulators of various biological processes (<xref ref-type="bibr" rid="bib28">Yao et al., 2019</xref>). The action modes of lncRNAs are complex. One major mechanism for them to exert their biological function in the intracellular is to interact with such as proteins, miRNAs, and mRNAs to alter protein translation, enzyme activity, protein degradation, etc (<xref ref-type="bibr" rid="bib24">Ulitsky and Bartel, 2013</xref>). For instance, lncRNA- <italic>CCRR</italic> was shown to inhibit the endocytic trafficking of connexin-43 by binding to CIP85 (<xref ref-type="bibr" rid="bib29">Zhang et al., 2018</xref>). <italic>LncDACH1</italic> mainly distributes in the intracellular, and can bind to SERCA2a to promote its ubiquitination and degradation (<xref ref-type="bibr" rid="bib4">Cai et al., 2019</xref>). <italic>lncDACH1</italic> can also bind to protein phosphatase 1 catalytic subunit alpha (PP1A) to inhibit its dephosphorylation activity on YAP1, leading to the intracellular sequestration of YAP1 (<xref ref-type="bibr" rid="bib5">Cai et al., 2020</xref>). The unraveling of the molecular mechanism of Nav1.5 is critical for the insightful understanding of sodium channel function under physiological and pathological conditions. Several interacting proteins have been demonstrated to determine the membrane distribution of Nav1.5 and sodium channel function (<xref ref-type="bibr" rid="bib1">Abriel et al., 2015</xref>). Dystrophin is a well-characterized Nav1.5 partner protein. It indirectly interacts with Nav1.5 via syntrophin, which binds with the C-terminus of dystrophin and with the SIV motif on the C-terminus of Nav1.5 (<xref ref-type="bibr" rid="bib7">Gavillet et al., 2006</xref>; <xref ref-type="bibr" rid="bib20">Shy et al., 2014</xref>). In this study, we found that <italic>lncDACH1</italic> binds to dystrophin and leads to the impairment of Nav1.5 trafficking and reduced membrane distribution.</p><p>Although the membrane distribution of both dystrophin and Nav1.5 was inhibited by <italic>lncDach1</italic>, the total protein level of dystrophin was not affected, while Nav1.5 was reduced. The mechanism for the differential influence of <italic>lncDach1</italic> on total protein levels of dystrophin and Nav1.5 is unclear. One explanation may be that Nav1.5 is a membrane-channel protein. If they failed to target on the plasma membrane, they may be regarded as unnecessary proteins and undergo the process of protein degradation. The E1-E3 enzymes in the ubiquitination systems have been shown to regulate the degradation of Nav1.5, which includes E1 enzyme UBE1 (Ubiquitin-activating Enzyme1), UBA6 (Ubiquitin-like modifier-activating enzyme 6), E2 enzyme, UBC9 (Ubiquitin-Conjugating Enzyme 9), and E3 ligase Nedd4-2 (neuronal precursor cell expressed developmentally downregulated 4–2) (<xref ref-type="bibr" rid="bib21">Tang et al., 2019</xref>; <xref ref-type="bibr" rid="bib26">van Bemmelen et al., 2004</xref>; <xref ref-type="bibr" rid="bib9">Hu et al., 2020</xref>). LITAF (lipopolysaccharide-induced tumor necrosis factor-alpha factor), a protein-encoding a regulator of endosomal trafficking, was shown to reduce surface Nav1.5 by promoting degradation of NEDD4-2 (<xref ref-type="bibr" rid="bib23">Turan et al., 2020</xref>). Therefore, intracellular Nav1.5 that failed to target on plasma membrane may be quickly distinguished and then degraded by these ubiquitination enzymes (<xref ref-type="fig" rid="fig8s3">Figure 8—figure supplement 3</xref>).</p><p>The dysfunction of the sodium channel is associated with various arrhythmias. Reduced peak <italic>I</italic><sub>Na</sub> due to <italic>Scn5a</italic> loss-of-function mutation can cause a series of arrhythmias such as atrial fibrillation, Brugada syndrome, long QT syndrome, sudden cardiac death, and ventricular tachycardia etc (<xref ref-type="bibr" rid="bib8">Han et al., 2018</xref>; <xref ref-type="bibr" rid="bib19">Savio-Galimberti et al., 2018</xref>). Consistently, we found that accompanied by the reduction of peak <italic>I</italic><sub>Na</sub>, overexpression of <italic>lncDach1</italic> reduced ventricular conduction velocity and increased the susceptibility to ventricular arrhythmia in mice. The increased peak <italic>I</italic><sub>Na</sub> due to <italic>Scn5a</italic> gain-of-function mutation is associated with arrhythmias such as atrial fibrillation, long QT syndrome; polymorphic ventricular complexes, and ventricular arrhythmia (<xref ref-type="bibr" rid="bib8">Han et al., 2018</xref>; <xref ref-type="bibr" rid="bib19">Savio-Galimberti et al., 2018</xref>). In this study, although the peak <italic>I</italic><sub>Na</sub> increased in <italic>lncDach1</italic>-cKO mice, the susceptibility to arrhythmia did not increase. One difference of our data with <italic>Scn5a</italic> gain-of-function mutation is that the kinetics of peak <italic>I</italic><sub>Na</sub> often change during mutation, while it is not the case of <italic>lncDach1</italic> knockout. One possible explanation may be that <italic>lncDach1</italic> does not alter Nav1.5 gating, and the late Na current may not be enhanced to the same effect as observed with LQT gain-of-function Nav1.5 mutations, in which APD prolongation is attributed to gating defects that increase late Na current.</p><p>Sodium channel remodeling occurs commonly in cardiac diseases, especially heart failure. Despite of some discrepancies, the main observations are that the peak <italic>I</italic><sub>Na</sub>, <italic>Scn5a</italic> mRNA, and Nav1.5 protein are reduced during heart failure in both human patients and animal models (<xref ref-type="bibr" rid="bib2">Baba et al., 2005</xref>; <xref ref-type="bibr" rid="bib25">Valdivia et al., 2005</xref>; <xref ref-type="bibr" rid="bib27">Xi et al., 2009</xref>; <xref ref-type="bibr" rid="bib6">Dybkova et al., 2018</xref>). In this study, we found that <italic>lncDach1</italic> was increased during heart failure, indicating that it may contribute to sodium channel remodeling and arrhythmogenesis during heart failure by interfering with the action of dystrophin. Interestingly, we found that activation of dystrophin with dCas9-SAM system restored the membrane distribution of Nav1.5 in cardiomyocytes of <italic>lncDach1</italic>-TG mice, which implies its potential in counteracting sodium channel remodeling of patients with heart failure.</p><p>The low sequence conservation of lncRNAs among species is a critical issue that limits the extrapolation of data from animal studies to human beings (<xref ref-type="bibr" rid="bib10">Johnsson et al., 2014</xref>; <xref ref-type="bibr" rid="bib22">Tsagakis et al., 2020</xref>). In this study, we found that the conserved fragment of <italic>lncDach1</italic> exhibits the same effect as <italic>lncDach1</italic> on Nav1.5 trafficking and arrhythmogenesis. Moreover, the human conservative homologous fragment of <italic>lncDACH1</italic> can inhibit the membrane distribution of Nav1.5 in cardiomyocytes derived from induced pluripotent stem cells (iPS-CMs). These findings hint at the clinical relevance of <italic>lncDACH1</italic>, which holds the potential to become a therapeutic target for treating sodium channel remodeling in clinic.</p><p>In conclusion, <italic>lncDACH1</italic> is a novel regulator of sodium channels, which suppresses the membrane trafficking of Nav1.5 by disturbing the function of dystrophin. The current work enriched our understanding of the biology of sodium channel trafficking and function, and indicated that lncRNAs possess the potential to become therapeutic targets for ventricular arrhythmias.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Animals</title><p>Neonatal (within 3 d post-born) and adult C57BL/6 mice (8–10 wk old) were provided by the animal center at the Second Affiliated Hospital of Harbin Medical University. Use of animals was approved by the IRB of the College of Pharmacy, Harbin Medical University, and conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85–23, revised 1996).</p></sec><sec id="s4-2"><title>Neonatal cardiomyocytes preparation</title><p>Neonatal cardiomyocytes were isolated from 3-day-old mice in accordance with the following procedures. Briefly, after dissection, hearts were washed and minced in 0.25% trypsin. Pooled cell suspensions were centrifuged and resuspended in Dulbecco’s modified Eagle’s medium (DMEM Hyclone, USA) supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100 μg/ml streptomycin. The suspension was incubated in culture flasks for 90 min, which makes fibroblasts preferentially adhere to the bottom of the culture flasks. Neonatal cardiomyocytes were removed from the culture flasks and the medium was changed. Cell cultures were incubated for 48 hr at 37 °C in a humidified atmosphere of 95% oxygen and 5% carbon dioxide before any experimentation.</p></sec><sec id="s4-3"><title>Generation of cardiac myocyte-specific <italic>lncDach1</italic> overexpressing mice</title><p>Cardiomyocyte-specific <italic>lncDach1</italic> overexpressing mice driven by murine <italic>Myh6</italic> promoter on a C57BL/6 background was generated by Biocytogen Co., Ltd (Beijing, China) as demonstrated in a previous study (<xref ref-type="bibr" rid="bib4">Cai et al., 2019</xref>).</p></sec><sec id="s4-4"><title>Generation of cardiomyocyte-specific <italic>lncDach1</italic> knockout mice</title><p><italic>LncDach1</italic> conditional KO mice (<italic>lncDach1</italic> Flox/Flox) were generated by using CRISPR/Cas9 technique on C57BL/6 background mice by Biocytogen Co., Ltd (Beijing, China) as demonstrated in a previous study (<xref ref-type="bibr" rid="bib4">Cai et al., 2019</xref>).</p></sec><sec id="s4-5"><title>Construction of adeno-associated virus 9 (AAV9) carrying deactivated clustered regularly interspaced short palindromic repeats associated protein 9 nuclease- synergistic activation mediator(dCas9-SAM) system to activate the transcription of dystrophin</title><p>AAV9 carrying dCas9-SAM system to activate the transcription of dystrophin was constructed as reported previously with brief modifications (<xref ref-type="bibr" rid="bib13">Maeder et al., 2013</xref>). The sgRNA targeting on the promoter region of dystrophin was designed and cloned into the multiple cloning site of plasmid GV639 (EFS-NLS-dSaCas9-NLS-VP64-bGHpA-U6). The constructed plasmid was packaged into the AAV9 virus. The sequence of sgRNA is: 5’- <named-content content-type="sequence">CGCTTCCGCGGCCCGTTCAA</named-content> –3’; The mock-sgRNA target sequence (5’-<named-content content-type="sequence">CGCTTCCGCGGCCCGTTCAA</named-content> –3’) was used as a negative control. The obtained AAV9 virus volume was administered into C57BL/6 mice via tail vein injection at 1×10<sup>11</sup> genome containing particles (GC)/animal in 100 µl.</p></sec><sec id="s4-6"><title>Construction of adenovirus carrying cF- <italic>lncDach1</italic> and in vivo gene delivery</title><p>Adenovirus vectors carrying cF- <italic>lncDach1</italic> (OE- cF- <italic>lncDach1</italic>) and a negative control (NC) and a CAG promoter conjugated with green fluorescent protein (GFP) were constructed by Genechem Co., Ltd. (Shanghai, China). OE- cF- <italic>lncDach1</italic>, control constructs at 1×10<sup>9</sup> genome containing particles (GC)/animal in 100 µl volume was administered into C57BL/6 mice with body weights ranging from 18~22 g via tail vein injection. Seventy-two hours after injection, the mice were subjected to further study.</p></sec><sec id="s4-7"><title>Construction of adenovirus carrying <italic>lncDach1</italic>, <italic>lncDach1</italic> siRNA, conserved fragment of human <italic>lncDach1</italic> and infection</title><p>Adenovirus vectors carrying <italic>lncDach1</italic> (OE-<italic>lncDach1</italic>), a short RNA fragment for silencing <italic>lncDach1</italic> (Si- <italic>lncDach1</italic>) or conserved fragment of human <italic>lncDach1</italic> (hcF- <italic>lncDach1</italic>) and a CAG promoter conjugated with green fluorescent protein (GFP) were constructed by Genechem Co., Ltd. (Shanghai, China). Neonatal cardiomyocytes were infected with adenovirus for 48 hr, and then subjected to subsequent study.</p></sec><sec id="s4-8"><title>Transfection of <italic>Hadhb, Eif4a1,</italic> and <italic>Anp32</italic> siRNA</title><p>siRNA for <italic>Hadhb</italic> (si<italic>Hadhb</italic>), <italic>Eif4a</italic>1(si<italic>Eif4a1</italic>), <italic>Anp32</italic>(si<italic>Anp32</italic>), and a scrambled negative control RNA (siNC) were synthesized by Generalbiol (Chuzhou, Anhui, China). These siRNAs were transfected at a final concentration of 100 nM into NMVMs using the X-treme GENE Transfection Reagent (Roche, Indianapolis, USA) according to the manufacturer’s protocols. The cardiomyocytes were collected for total RNA isolation or protein purification.</p></sec><sec id="s4-9"><title>Induction of ventricular arrhythmia</title><p>C57BL/6 mice were anesthetized with 2,2,2-tribromoethanol (200 mg/kg, i.p.). An octapolar electrophysiological catheter (1.1 F, SciSense Inc, Canada) was inserted into the right ventricle via the jugular vein. Intracardiac pacing was performed using an automated stimulator interfaced with the data acquisition system (GY6000; HeNan HuaNan Medical Science &amp; Technology Ltd., Zhengzhou, China). The surface recording electrode was fixed on the LV epicardium to record pseudo-ECG. Inducibility of VT was determined by applying a train of ten consecutive electrical pulses with a coupling interval of 80 ms (S1), followed by two extra stimuli (S2 and S3) at coupling intervals of 2 ms, respectively. Successful induction of VT was defined as the appearance of rapid nonsinus rhythm ventricular activations lasting for three beats or more.</p></sec><sec id="s4-10"><title>Optical mapping recording</title><p>Mice were heparinized and euthanized by 2,2,2-tribromoethanol (200 mg/kg, intraperitoneal injection; Sigma, St Louis, MO, USA). The heart was isolated and Langendorff perfused with Tyrode’s solution (NaCl 128.2 mM, CaCl<sub>2</sub>•2H<sub>2</sub>O 1.3 mM, KCl 4.7 mM, MgCl<sub>2</sub>•6H<sub>2</sub>O 1.85 mM, NaH<sub>2</sub>PO<sub>4</sub>•2H<sub>2</sub>O 1.19 mM, Na<sub>2</sub>CO3 20 mM, and glucose 11.1 mM; pH 7.35) at 37 °C. After 10 min of stabilization, the hearts were stained with RH237 (10 μM) for membrane voltage (Vm) mapping. The dye was excited at 710 nm using a monochromatic light-emitting device. The fluorescence was filtered and recorded simultaneously with a MiCAM05 CMOS camera (SciMedia, USA) at 1 ms/frame and 100x100 pixels with a spatial resolution of 0.35×0.35 mm<sup>2</sup> per pixel. Blebbistatin (10 µM, Selleckchem, Houston, TX, USA) was used to inhibit motion artifacts during optical mapping.</p></sec><sec id="s4-11"><title>Experimental protocol of optical mapping</title><p>A pair of hook bipolar electrodes was inserted into the apex of the heart for pacing. A pseudo-ECG was obtained with widely spaced bipolar electrodes to determine ventricular rhythm. The ventricles were initially paced at a constant pacing cycle length (PCL) of 200 ms. The PCLs were progressively shortened (200, 100, 60, 40, 30, 20 ms) with a duration of 1–2 s until VT was induced or the loss of 1:1 capture of the ventricles. Optical recording was performed after 20 beats of stable pacing at each PCL. Optical recordings were then performed during VT.</p></sec><sec id="s4-12"><title>Patch-clamp recording</title><p>Whole-cell configuration of the patch-clamp technique was used to record peak <italic>I</italic><sub>Na</sub> and the inward rectifier K<sup>+</sup> current (<italic>I</italic><sub>K1</sub>). <italic>I</italic><sub>Na</sub> recordings were performed at room temperature (22~23 °C) by using a MultiClamp 700B (Alembic Instruments) amplifier. Pipettes (tip resistance 1–2 MΩ) were filled with a solution containing (in mM): NaCl 5, CaCl<sub>2</sub> 2, MgCl<sub>2</sub> 2, CsCl 130, HEPES 10, EGTA 15, and MgATP 4 (pH 7.2 with CsOH). Myocytes were bathed with a solution containing (in mM): NaCl 25, CaCl<sub>2</sub> 2, MgCl<sub>2</sub> 2.5, CsCl 108.5, HEPES 10, CoCl<sub>2</sub> 2.5, and glucose 10 (pH 7.4 with CsOH). <italic>I</italic><sub>K1</sub> was measured as a Ba<sup>2+</sup>-sensitive steady-state current and treated with 300 µmol/L Ba<sup>2+</sup> recording at 37 C using a patch clamp amplifier (MultiClamp 700B). The external solution for recording <italic>I</italic><sub>K1</sub> contained (in mM): NaCl 136, KCl 5.4, NAH<sub>2</sub>PO<sub>4</sub> 0.33, MgCl<sub>2</sub>·6H<sub>2</sub>O 1, CaCl<sub>2</sub> 1.8, HEPES 5 and glucose 10 (pH 7.37 with NaOH). The pipette solution for recording <italic>I</italic><sub>K1</sub> contained (in mM): KCl 20, K-aspartate 110, HEPES 5, MgCl<sub>2</sub> 1, Na<sub>2</sub>ATP 5, and EGTA 10 (pH 7.20 with KOH).</p></sec><sec id="s4-13"><title>Differentiation of human induced pluripotent stem cells(hiPSCs) to cardiomyocytes</title><p>Undifferentiated hiPS cells (AC-iPSC) were purchased from NC5 (Help Stem Cell Innovations, NC2001) and cultured on Matrigel-coated plates in an E8 medium (CA1001500, CELLAPY). The iPSCs were generated from PBMCs. Flow cytometry analysis and immunofluorescence analysis show that the iPSCs demonstrated high expression levels of pluripotency markers (TRA-1–60, SSEA4, and OCT4). The iPSCs tested negative for mycoplasma contamination. Differentiation basal medium composed of RPMI1640 medium (C11875500BT, Thermo Fisher Scientific) and B27 minus insulin (A1895601, Thermo Fisher Scientific) was used to induce cardiomyocyte differentiation. Specifically, the 70~80% confluent hiPSCs were incubated in differentiation basal medium added with CHIR-99021 (HY-10182, MCE) for 1 d and Wnt-C59 (S7037, Selleck Chemicals) for 2 d. Then, the cells were cultured in RPMI1640 basal medium containing B27 (17504044, Thermo Fisher Scientific), which was replaced with fresh medium every 1~2 d. Beating cells were observed after 8 d of differentiation induction and used for further study.</p></sec><sec id="s4-14"><title>Construction of truncated <italic>LncDach1</italic> fragment plasmids</title><p>The sequence of <italic>lncDach1</italic> was divided into five fragments. The cDNA of each fragment was inserted into the pCDNA3.1, respectively. The first 417 nts of the entire sequences were cut off and constructed as fragment-a (418–2085 nts). Another 417 nts was cut off to generate fragment-b (835–2085 nts). The third 417 nts was cut off to generate fragment-c (1251–2085 nts). Fragment-d is from 835 to 1668 nts, and fragment-e is from 835 to 1251 nts.</p></sec><sec id="s4-15"><title>Isolation of cardiac myocytes</title><p>Hearts were rapidly excised, cannulated, and perfused with Ca<sup>2+</sup> -free Tyrode solution (in mM): NaCl 137, KCl 5.4, NaH<sub>2</sub>PO<sub>4</sub> 0.16, glucose 10, CaCl<sub>2</sub> 1.8, MgCl<sub>2</sub> 0.5, HEPES 5.0, and NaHCO<sub>3</sub> 3.0 (pH 7.4 adjusted with NaOH) for 5 min. The heart was then perfused with a solution containing collagenases B and D (Roche) and protease XIV (Sigma) until digestion was complete. Tissue was dissociated using forceps, and dissociated left ventricular cardiomyocytes were gradually exposed to Ca<sup>2+</sup> (from 50 to 500 µM over 40 min) and plated in culture chambers for further studies.</p></sec><sec id="s4-16"><title>Immunocytochemistry of isolated mouse ventricular myocytes</title><p>Cardiomyocytes were fixed for 10 min with 4% paraformaldehyde in PBS, and then washed in PBS for 10 min (two times). The cells were permeabilized with 0.5% Tween 20 for 30 min. After being washed out with PBS for 10 min (three times), cardiomyocytes were incubated with primary antibodies against Nav1.5 (ASC005, Alomone, 1;200) and dystrophin (MANDYS8, SIGMA, 1;300) overnight at 4 °C. Following washout with PBS (10 min, three times), cells were incubated with secondary antibodies for 1 hr and washed with PBS (10 min, three times). The coverslips were mounted onto frosted slides in a solution composed of 90% FluorSave Reagent (Calbiochem, La Jolla, CA, USA) and 10% 10 X PBS.</p></sec><sec id="s4-17"><title>Fluorescent in situ hybridization (FISH)</title><p>In situ hybridization was performed with a FISH Kit (RiboBio, Guangzhou, China). Briefly, isolated cardiomyocytes were fixed in 4% formaldehyde at 4 °C for 10 min and dried out on the slides at room temperature (RT). The slides were rinsed and permeabilized with 0.5% Triton-100 in PBS at RT for 30 min, washed with PBS solution, and prehybridized at 37 °C for 30 min before hybridization. The prehybridized slides were then incubated with lncRNA-probe in a hybridization solution at 37 °C for 16 hr. After hybridization, the slides were washed six times with prewarmed wash buffer and PBS solution. Finally, the slides were counterstained with DAPI and visualized using a confocal laser-scanning microscope (Zeiss 800, Germany).</p></sec><sec id="s4-18"><title>Quantitative real-time RT-PCR</title><p>Total RNA was extracted by using Trizol reagent (Invitrogen, USA) according to the manufacturer’s protocol. Total RNA (0.5 μg) was reverse transcribed by using the TransScript reverse transcriptase (GMO technology, Beijing) to obtain cDNA. The RNA levels were determined using SYBR Green I incorporation method on ABI 7500 fast Real-Time PCR system (Applied Biosystems, USA), The expression levels of mRNA were calculated using the comparative cycle threshold (Ct) method (2−ΔΔCt). Each data point was then normalized to <italic>Actin</italic> as an internal control in each sample. The final results are expressed as fold changes by normalizing the data to the values from control subjects. Primers used in this study were listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> .</p></sec><sec id="s4-19"><title>Western blot</title><p>The total, membrane, and intracellular protein samples were extracted from cardiac tissues of C57BL/6 mice for immunoblotting analysis. Total protein was collected with the treatment of RIPA lysis buffer (Beyotime, Beijing, China) and a protease inhibitor cocktail (Roche, Basel, Switzerland) at 4 °C followed by centrifugation. Extraction of surface and intracellular proteins was conducted using the Surface and Intracellular Protein Reagent Kit (Cat#P0033; Beyotime, Shanghai, China) according to the manufacturer’s instructions. Protein samples were fractionated by SDS-PAGE and then transferred to the PVDF membrane. The membranes were blocked in Tris-buffered saline containing 5% milk and then incubated with primary antibodies at 4 °C overnight. The primary antibodies include anti-Nav1.5 (ASC005, Alomone, 1:200), anti-dystrophin (MANDYS8, SIGMA, 1:500). The anti-β-actin (1:20000 dilution, 66009–1-Ig, Proteintech), and anti-N-cadherin antibody (Cat#ab76011, 1:5000; Abcam, Cambridge, UK) were used as internal controls. Western blot bands were captured on the Odyssey Infrared Imaging System (LI-COR Biosciences, USA) and quantified with Odyssey v1.2 software by measuring the band intensity (area ×OD) in each group. The band intensity was normalized to the internal control. All antibodies were diluted in PBS buffer.</p></sec><sec id="s4-20"><title>RNA pulldown and immunoblotting</title><p>The RNA pull-down was performed as described in the previous study (<xref ref-type="bibr" rid="bib4">Cai et al., 2019</xref>). Briefly, Biotin-labeled, full-length <italic>lncDach1</italic> RNA and antisense RNA were prepared with the Biotin RNA Labeling Mix (Roche) and T7 RNA polymerase (Roche). Biotinylated RNAs were treated with RNase-free DNase I (Invitrogen) and purified on G-50 Sephadex Quick Spin columns (Roche). Biotinylated RNA (17 μg) was heated to 65 °C for 10 min and slowly cooled to 4 °C. Then the RNA was mixed with tissue extracts in pulldown buffer supplemented with tRNA (0.1 μg/μl) and incubated at 4 °C for 2 hr. Washed Streptavidin agarose beads (60 μl, Invitrogen) were added to each binding reaction and further incubated at 4 °C for 1 hr. Beads were washed briefly five times in pulldown buffer and boiled in SDS buffer, and the retrieved protein was visualized by immunoblotting.</p></sec><sec id="s4-21"><title>RNA immunoprecipitation (RIP)</title><p>RIP experiments were performed by using a Magna RIPTM RNA-Binding Protein Immunoprecipitation Kit (Millipore, USA) as previously reported (<xref ref-type="bibr" rid="bib4">Cai et al., 2019</xref>). Briefly, heart tissue was pieced and lysed in 220 μl of lysis buffer containing protease inhibitors and RNase Inhibitor and centrifuged at 14,000×g for 10 min. The supernatants were incubated with anti-dystrophin, anti-hadhb, and anti-rabbit IgG antibody for overnight at 4 °C with gentle rotation. Protein G magnetic beads (50 μl) were added and incubated at RT with gentle rotation for 3 hr. RNA was extracted with 400 μl phenol:chloroform:isoamyl alcohol (125:24:1, pH = 4.3) according to the manufacturer’s instructions before quantitation by RT-qPCR.</p></sec><sec id="s4-22"><title>Mouse models of heart failure (HF) by transaortic constriction (TAC) and by coronary artery ligation</title><p>Mice were randomly divided into sham and TAC groups. In each group, mice were anesthetized with 2,2,2-tribromoethanol (200 mg/kg, i.p.) for the TAC model. The animal was orally intubated with a 20-gauge tube, and ventilated (mouse ventilator, UGO BASILE, Biological Research Apparatus, Italy) at the respiratory rate of 100 breaths/min with a tidal volume of 0.3 ml. The transverse aorta was constricted by a 6–0 silk suture ligature tied firmly against a 27-gauge needle between the carotid arteries. Then, the needle was promptly removed to yield a constriction of 0.4 mm in diameter. For sham group mice, the animals received the same procedures without aorta constriction.</p></sec><sec id="s4-23"><title>Statistical analysis</title><p>Data are expressed as mean ± SEM. Statistical analysis was performed using unpaired Student’s t-test or One-Way Analysis of Variance (ANOVA) followed by Tukey’s post-hoc analysis. A p&lt;0.05 was considered statistically different.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Methodology, Writing – original draft, Project administration</p></fn><fn fn-type="con" id="con2"><p>Data curation, Validation, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Supervision, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Supervision, Validation, Investigation</p></fn><fn fn-type="con" id="con5"><p>Supervision, Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Supervision, Validation</p></fn><fn fn-type="con" id="con7"><p>Supervision, Validation, Investigation</p></fn><fn fn-type="con" id="con8"><p>Supervision, Validation</p></fn><fn fn-type="con" id="con9"><p>Supervision, Validation</p></fn><fn fn-type="con" id="con10"><p>Formal analysis, Supervision, Validation</p></fn><fn fn-type="con" id="con11"><p>Formal analysis, Supervision, Validation</p></fn><fn fn-type="con" id="con12"><p>Supervision, Validation</p></fn><fn fn-type="con" id="con13"><p>Supervision, Validation</p></fn><fn fn-type="con" id="con14"><p>Supervision, Validation</p></fn><fn fn-type="con" id="con15"><p>Supervision, Validation</p></fn><fn fn-type="con" id="con16"><p>Supervision, Validation</p></fn><fn fn-type="con" id="con17"><p>Supervision, Validation</p></fn><fn fn-type="con" id="con18"><p>Supervision, Validation</p></fn><fn fn-type="con" id="con19"><p>Supervision, Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con20"><p>Resources, Supervision, Funding acquisition, Validation, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con21"><p>Conceptualization, Resources, Data curation, Funding acquisition, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>The study was conducted in accordance with the Declaration of Helsinki, all experimental procedures complied with IRB of College of Pharmacy,Harbin Medical University (Approval Number: IRB2004821).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-89690-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>List of primers used in this study.</title></caption><media xlink:href="elife-89690-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Alignment of murine lncDACH1.</title></caption><media xlink:href="elife-89690-supp2-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript source data and supplementary files.</p></sec><ack id="ack"><title>Acknowledgements</title><p>G Xue, Y Zhang, J Yang, performed experiments, analyzed data, and prepared the manuscript. Y Yang, R Zhang, D Li, T Tian, J Li, X Zhang, C Li, X Li, J Yang, K Shen, Y Guo, X Liu, and G Yang helped perform experiments and collect data. B Yang and Y Lu oversaw the project and proofread the manuscript. Z Pan designed the project, oversaw the experiments and prepared the manuscript. This work was supported by National Key R&amp;D Program of China (2017YFC1307404 to Z P), National Natural Science Foundation of China (82070344, 81870295 to Z P 81730012, 81861128022 to B Y), Heilongjiang Touyan Innovation Team Program, and CAMS Innovation Fund for Medical Sciences (CIFMS, 2019-I2M-5–078 to B Y).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abriel</surname><given-names>H</given-names></name><name><surname>Rougier</surname><given-names>JS</given-names></name><name><surname>Jalife</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Ion channel macromolecular complexes in cardiomyocytes: roles in sudden cardiac death</article-title><source>Circulation Research</source><volume>116</volume><fpage>1971</fpage><lpage>1988</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.305017</pub-id><pub-id pub-id-type="pmid">26044251</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baba</surname><given-names>S</given-names></name><name><surname>Dun</surname><given-names>W</given-names></name><name><surname>Cabo</surname><given-names>C</given-names></name><name><surname>Boyden</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Remodeling in cells from different regions of the reentrant circuit during ventricular tachycardia</article-title><source>Circulation</source><volume>112</volume><fpage>2386</fpage><lpage>2396</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.105.534784</pub-id><pub-id pub-id-type="pmid">16203911</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bär</surname><given-names>C</given-names></name><name><surname>Chatterjee</surname><given-names>S</given-names></name><name><surname>Thum</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Long noncoding RNAs in cardiovascular pathology, diagnosis, and therapy</article-title><source>Circulation</source><volume>134</volume><fpage>1484</fpage><lpage>1499</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.116.023686</pub-id><pub-id pub-id-type="pmid">27821419</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Jin</surname><given-names>X</given-names></name><name><surname>Xue</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Su</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Pan</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Long noncoding RNA-DACH1 (dachshund homolog 1) regulates cardiac function by inhibiting SERCA2a (sarcoplasmic reticulum calcium atpase 2a)</article-title><source>Hypertension</source><volume>74</volume><fpage>833</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.119.12998</pub-id><pub-id pub-id-type="pmid">31446800</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>B</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Sukhareva</surname><given-names>N</given-names></name><name><surname>Hua</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>R</given-names></name><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Han</surname><given-names>Z</given-names></name><name><surname>Ding</surname><given-names>F</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Bamba</surname><given-names>D</given-names></name><name><surname>Zagidullin</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Pan</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Targeting LncDACH1 promotes cardiac repair and regeneration after myocardium infarction</article-title><source>Cell Death and Differentiation</source><volume>27</volume><fpage>2158</fpage><lpage>2175</lpage><pub-id pub-id-type="doi">10.1038/s41418-020-0492-5</pub-id><pub-id pub-id-type="pmid">31969690</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dybkova</surname><given-names>N</given-names></name><name><surname>Ahmad</surname><given-names>S</given-names></name><name><surname>Pabel</surname><given-names>S</given-names></name><name><surname>Tirilomis</surname><given-names>P</given-names></name><name><surname>Hartmann</surname><given-names>N</given-names></name><name><surname>Fischer</surname><given-names>TH</given-names></name><name><surname>Bengel</surname><given-names>P</given-names></name><name><surname>Tirilomis</surname><given-names>T</given-names></name><name><surname>Ljubojevic</surname><given-names>S</given-names></name><name><surname>Renner</surname><given-names>A</given-names></name><name><surname>Gummert</surname><given-names>J</given-names></name><name><surname>Ellenberger</surname><given-names>D</given-names></name><name><surname>Wagner</surname><given-names>S</given-names></name><name><surname>Frey</surname><given-names>N</given-names></name><name><surname>Maier</surname><given-names>LS</given-names></name><name><surname>Streckfuss-Bömeke</surname><given-names>K</given-names></name><name><surname>Hasenfuss</surname><given-names>G</given-names></name><name><surname>Sossalla</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Differential regulation of sodium channels as a novel proarrhythmic mechanism in the human failing heart</article-title><source>Cardiovascular Research</source><volume>114</volume><fpage>1728</fpage><lpage>1737</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvy152</pub-id><pub-id pub-id-type="pmid">29931291</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavillet</surname><given-names>B</given-names></name><name><surname>Rougier</surname><given-names>JS</given-names></name><name><surname>Domenighetti</surname><given-names>AA</given-names></name><name><surname>Behar</surname><given-names>R</given-names></name><name><surname>Boixel</surname><given-names>C</given-names></name><name><surname>Ruchat</surname><given-names>P</given-names></name><name><surname>Lehr</surname><given-names>HA</given-names></name><name><surname>Pedrazzini</surname><given-names>T</given-names></name><name><surname>Abriel</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cardiac sodium channel Nav1.5 is regulated by a multiprotein complex composed of syntrophins and dystrophin</article-title><source>Circulation Research</source><volume>99</volume><fpage>407</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000237466.13252.5e</pub-id><pub-id pub-id-type="pmid">16857961</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>D</given-names></name><name><surname>Tan</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Dysfunctional Nav1.5 channels due to SCN5A mutations</article-title><source>Experimental Biology and Medicine</source><volume>243</volume><fpage>852</fpage><lpage>863</lpage><pub-id pub-id-type="doi">10.1177/1535370218777972</pub-id><pub-id pub-id-type="pmid">29806494</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Bai</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Chakrabarti</surname><given-names>S</given-names></name><name><surname>Tang</surname><given-names>B</given-names></name><name><surname>Xiong</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>QK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Ubiquitination-activating enzymes UBE1 and UBA6 regulate ubiquitination and expression of cardiac sodium channel Nav1.5</article-title><source>The Biochemical Journal</source><volume>477</volume><fpage>1683</fpage><lpage>1700</lpage><pub-id pub-id-type="doi">10.1042/BCJ20200138</pub-id><pub-id pub-id-type="pmid">32315024</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnsson</surname><given-names>P</given-names></name><name><surname>Lipovich</surname><given-names>L</given-names></name><name><surname>Grandér</surname><given-names>D</given-names></name><name><surname>Morris</surname><given-names>KV</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Evolutionary conservation of long non-coding RNAs; sequence, structure, function</article-title><source>Biochimica et Biophysica Acta</source><volume>1840</volume><fpage>1063</fpage><lpage>1071</lpage><pub-id pub-id-type="doi">10.1016/j.bbagen.2013.10.035</pub-id><pub-id pub-id-type="pmid">24184936</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lapidos</surname><given-names>KA</given-names></name><name><surname>Kakkar</surname><given-names>R</given-names></name><name><surname>McNally</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma</article-title><source>Circulation Research</source><volume>94</volume><fpage>1023</fpage><lpage>1031</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000126574.61061.25</pub-id><pub-id pub-id-type="pmid">15117830</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>Q-Q</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y-F</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>H-J</given-names></name><name><surname>Chen</surname><given-names>B-R</given-names></name><name><surname>Meng</surname><given-names>H-Y</given-names></name><name><surname>Wang</surname><given-names>Q-M</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>Z-M</given-names></name><name><surname>Wang</surname><given-names>L-S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Long Noncoding rna kcna2 antisense rna contributes to ventricular arrhythmias via silencing kcna2 in rats with congestive heart failure</article-title><source>Journal of the American Heart Association</source><volume>6</volume><elocation-id>e005965</elocation-id><pub-id pub-id-type="doi">10.1161/JAHA.117.005965</pub-id><pub-id pub-id-type="pmid">29263036</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maeder</surname><given-names>ML</given-names></name><name><surname>Linder</surname><given-names>SJ</given-names></name><name><surname>Cascio</surname><given-names>VM</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Ho</surname><given-names>QH</given-names></name><name><surname>Joung</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>CRISPR RNA-guided activation of endogenous human genes</article-title><source>Nature Methods</source><volume>10</volume><fpage>977</fpage><lpage>979</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2598</pub-id><pub-id pub-id-type="pmid">23892898</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marionneau</surname><given-names>C</given-names></name><name><surname>Abriel</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Regulation of the cardiac Na+ channel NaV1.5 by post-translational modifications</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>82</volume><fpage>36</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2015.02.013</pub-id><pub-id pub-id-type="pmid">25748040</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petitprez</surname><given-names>S</given-names></name><name><surname>Zmoos</surname><given-names>A-F</given-names></name><name><surname>Ogrodnik</surname><given-names>J</given-names></name><name><surname>Balse</surname><given-names>E</given-names></name><name><surname>Raad</surname><given-names>N</given-names></name><name><surname>El-Haou</surname><given-names>S</given-names></name><name><surname>Albesa</surname><given-names>M</given-names></name><name><surname>Bittihn</surname><given-names>P</given-names></name><name><surname>Luther</surname><given-names>S</given-names></name><name><surname>Lehnart</surname><given-names>SE</given-names></name><name><surname>Hatem</surname><given-names>SN</given-names></name><name><surname>Coulombe</surname><given-names>A</given-names></name><name><surname>Abriel</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>SAP97 and dystrophin macromolecular complexes determine two pools of cardiac sodium channels Nav1.5 in cardiomyocytes</article-title><source>Circulation Research</source><volume>108</volume><fpage>294</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.110.228312</pub-id><pub-id pub-id-type="pmid">21164104</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinn</surname><given-names>JJ</given-names></name><name><surname>Chang</surname><given-names>HY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Unique features of long non-coding RNA biogenesis and function</article-title><source>Nature Reviews. Genetics</source><volume>17</volume><fpage>47</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1038/nrg.2015.10</pub-id><pub-id pub-id-type="pmid">26666209</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rook</surname><given-names>MB</given-names></name><name><surname>Evers</surname><given-names>MM</given-names></name><name><surname>Vos</surname><given-names>MA</given-names></name><name><surname>Bierhuizen</surname><given-names>MFA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Biology of cardiac sodium channel Nav1.5 expression</article-title><source>Cardiovascular Research</source><volume>93</volume><fpage>12</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvr252</pub-id><pub-id pub-id-type="pmid">21937582</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruan</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Priori</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Sodium channel mutations and arrhythmias</article-title><source>Nature Reviews. Cardiology</source><volume>6</volume><fpage>337</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1038/nrcardio.2009.44</pub-id><pub-id pub-id-type="pmid">19377496</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Savio-Galimberti</surname><given-names>E</given-names></name><name><surname>Argenziano</surname><given-names>M</given-names></name><name><surname>Antzelevitch</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><chapter-title>Cardiac arrhythmias related to sodium channel dysfunction</chapter-title><person-group person-group-type="editor"><name><surname>Argenziano</surname><given-names>M</given-names></name><name><surname>Antzelevitch</surname><given-names>C</given-names></name></person-group><source>Handbook of Experimental Pharmacology</source><publisher-name>Springer</publisher-name><fpage>331</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1007/164_2017_43</pub-id><pub-id pub-id-type="pmid">28965168</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shy</surname><given-names>D</given-names></name><name><surname>Gillet</surname><given-names>L</given-names></name><name><surname>Ogrodnik</surname><given-names>J</given-names></name><name><surname>Albesa</surname><given-names>M</given-names></name><name><surname>Verkerk</surname><given-names>AO</given-names></name><name><surname>Wolswinkel</surname><given-names>R</given-names></name><name><surname>Rougier</surname><given-names>J-S</given-names></name><name><surname>Barc</surname><given-names>J</given-names></name><name><surname>Essers</surname><given-names>MC</given-names></name><name><surname>Syam</surname><given-names>N</given-names></name><name><surname>Marsman</surname><given-names>RF</given-names></name><name><surname>van Mil</surname><given-names>AM</given-names></name><name><surname>Rotman</surname><given-names>S</given-names></name><name><surname>Redon</surname><given-names>R</given-names></name><name><surname>Bezzina</surname><given-names>CR</given-names></name><name><surname>Remme</surname><given-names>CA</given-names></name><name><surname>Abriel</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>PDZ domain-binding motif regulates cardiomyocyte compartment-specific NaV1.5 channel expression and function</article-title><source>Circulation</source><volume>130</volume><fpage>147</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.113.007852</pub-id><pub-id pub-id-type="pmid">24895455</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>B</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Cheng</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Liang</surname><given-names>L</given-names></name><name><surname>Xiong</surname><given-names>H</given-names></name><name><surname>Luo</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>QK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>UBC9 regulates cardiac sodium channel Na<sub>v</sub>1.5 ubiquitination, degradation and sodium current density</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>129</volume><fpage>79</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2019.02.007</pub-id><pub-id pub-id-type="pmid">30772377</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsagakis</surname><given-names>I</given-names></name><name><surname>Douka</surname><given-names>K</given-names></name><name><surname>Birds</surname><given-names>I</given-names></name><name><surname>Aspden</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Long non-coding RNAs in development and disease: conservation to mechanisms</article-title><source>The Journal of Pathology</source><volume>250</volume><fpage>480</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1002/path.5405</pub-id><pub-id pub-id-type="pmid">32100288</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turan</surname><given-names>NN</given-names></name><name><surname>Moshal</surname><given-names>KS</given-names></name><name><surname>Roder</surname><given-names>K</given-names></name><name><surname>Baggett</surname><given-names>BC</given-names></name><name><surname>Kabakov</surname><given-names>AY</given-names></name><name><surname>Dhakal</surname><given-names>S</given-names></name><name><surname>Teramoto</surname><given-names>R</given-names></name><name><surname>Chiang</surname><given-names>DY-E</given-names></name><name><surname>Zhong</surname><given-names>M</given-names></name><name><surname>Xie</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Dudley</surname><given-names>SC</given-names><suffix>Jr</suffix></name><name><surname>MacRae</surname><given-names>CA</given-names></name><name><surname>Karma</surname><given-names>A</given-names></name><name><surname>Koren</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The endosomal trafficking regulator LITAF controls the cardiac Nav1.5 channel via the ubiquitin ligase NEDD4-2</article-title><source>The Journal of Biological Chemistry</source><volume>295</volume><fpage>18148</fpage><lpage>18159</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA120.015216</pub-id><pub-id pub-id-type="pmid">33093176</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulitsky</surname><given-names>I</given-names></name><name><surname>Bartel</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>lincRNAs: genomics, evolution, and mechanisms</article-title><source>Cell</source><volume>154</volume><fpage>26</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.06.020</pub-id><pub-id pub-id-type="pmid">23827673</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valdivia</surname><given-names>CR</given-names></name><name><surname>Chu</surname><given-names>WW</given-names></name><name><surname>Pu</surname><given-names>J</given-names></name><name><surname>Foell</surname><given-names>JD</given-names></name><name><surname>Haworth</surname><given-names>RA</given-names></name><name><surname>Wolff</surname><given-names>MR</given-names></name><name><surname>Kamp</surname><given-names>TJ</given-names></name><name><surname>Makielski</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Increased late sodium current in myocytes from a canine heart failure model and from failing human heart</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>38</volume><fpage>475</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2004.12.012</pub-id><pub-id pub-id-type="pmid">15733907</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Bemmelen</surname><given-names>MX</given-names></name><name><surname>Rougier</surname><given-names>J-S</given-names></name><name><surname>Gavillet</surname><given-names>B</given-names></name><name><surname>Apothéloz</surname><given-names>F</given-names></name><name><surname>Daidié</surname><given-names>D</given-names></name><name><surname>Tateyama</surname><given-names>M</given-names></name><name><surname>Rivolta</surname><given-names>I</given-names></name><name><surname>Thomas</surname><given-names>MA</given-names></name><name><surname>Kass</surname><given-names>RS</given-names></name><name><surname>Staub</surname><given-names>O</given-names></name><name><surname>Abriel</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Cardiac voltage-gated sodium channel Nav1.5 is regulated by Nedd4-2 mediated ubiquitination</article-title><source>Circulation Research</source><volume>95</volume><fpage>284</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000136816.05109.89</pub-id><pub-id pub-id-type="pmid">15217910</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xi</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>K</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Lei</surname><given-names>X</given-names></name><name><surname>Bai</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Increased late sodium currents are related to transcription of neuronal isoforms in a pressure-overload model</article-title><source>European Journal of Heart Failure</source><volume>11</volume><fpage>749</fpage><lpage>757</lpage><pub-id pub-id-type="doi">10.1093/eurjhf/hfp092</pub-id><pub-id pub-id-type="pmid">19584134</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>RW</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>LL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cellular functions of long noncoding RNAs</article-title><source>Nature Cell Biology</source><volume>21</volume><fpage>542</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.1038/s41556-019-0311-8</pub-id><pub-id pub-id-type="pmid">31048766</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Xuan</surname><given-names>L</given-names></name><name><surname>Pan</surname><given-names>Z</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Bai</surname><given-names>Y</given-names></name><name><surname>Jiao</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Cui</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>T</given-names></name><name><surname>Feng</surname><given-names>B</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Meng</surname><given-names>W</given-names></name><name><surname>Ren</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Shan</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Long non-coding RNA CCRR controls cardiac conduction via regulating intercellular coupling</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>4176</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06637-9</pub-id><pub-id pub-id-type="pmid">30301979</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Ren</surname><given-names>H</given-names></name><name><surname>Shen</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Long noncoding RNA MALAT1 downregulates cardiac transient outward potassium current by regulating miR-200c/HMGB1 pathway</article-title><source>Journal of Cellular Biochemistry</source><volume>119</volume><fpage>10239</fpage><lpage>10249</lpage><pub-id pub-id-type="doi">10.1002/jcb.27366</pub-id><pub-id pub-id-type="pmid">30145795</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89690.4.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Colecraft</surname><given-names>Henry M</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Columbia University</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This study presents an <bold>important</bold> contribution to cardiac arrhythmia research by demonstrating long noncoding RNA Dachshund homolog 1 (lncDACH1) tunes sodium channel functional expression and affects cardiac action potential conduction and rhythms. The evidence supporting the major claims are <bold>convincing</bold>. The work will be of broad interest to cell biologists and cardiac electrophysiologists.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89690.4.sa1</article-id><title-group><article-title>Reviewer #1 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In this study, the authors show that a long-non coding RNA lncDACH1 inhibits sodium currents in cardiomyocytes by binding to and altering the localization of dystrophin. The authors use a number of methodologies to demonstrate that lncDACH1 binds to dystrophin and disrupts its localization to the membrane, which in turn downregulates NaV1.5 currents. Knockdown of lncDACH1 upregulates NaV1.5 currents. Furthermore, in heart failure, lncDACH1 is shown to be upregulated which suggests that this mechanism may have pathophysiological relevance.</p><p>Strengths:</p><p>(1) This study presents a novel mechanism of Na channel regulation which may be pathophysiologically important.</p><p>(2) The experiments are comprehensive and systematically evaluate the physiological importance of lncDACH1.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89690.4.sa2</article-id><title-group><article-title>Reviewer #2 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>This manuscript by Xue et al. describes the effects of a long noncoding RNA, lncDACH1, on the localization of Nav channel expression, the magnitude of INa, and arrhythmia susceptibility in the mouse heart. Because lncDACH1 was previously reported to bind and disrupt membrane expression of dystrophin, which in turn is required for proper Nav1.5 localization, much of the findings are inferred through the lens of dystrophin alterations.</p><p>The results report that cardiomyocyte-specific transgenic overexpression of lncDACH1 reduces INa in isolated cardiomyocytes; measurements in the whole heart show a corresponding reduction in conduction velocity and enhanced susceptibility to arrhythmia. The effect on INa was confirmed in isolated WT mouse cardiomyocytes infected with a lncDACH1 adenoviral construct. Importantly, reducing lncDACH1 expression via either a cardiomyocyte-specific knockout or using shRNA had the opposite effect: INa was increased in isolated cells, as was conduction velocity in the heart. Experiments were also conducted with a fragment of lnDACH1 identified by its conservation with other mammalian species. Overexpression of this fragment resulted in reduced INa and greater proarrhythmic behavior. Alteration of expression was confirmed by qPCR.</p><p>The mechanism by which lnDACH1 exerts its effects on INa was explored by measuring protein levels from cell fractions and immunofluorescence localization in cells. In general, overexpression was reported to reduce Nav1.5 and dystrophin levels and knockout or knockdown increased them.</p><p>The strengths of this manuscript include convincing evidence of a link between lncDACH1 and Na channel function. The identification of a lncDACH1 segment conserved among mammalian species is compelling. The observation that lncDACH1 is increased in a heart failure model and provides a plausible hypothesis for disease mechanism.</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89690.4.sa3</article-id><title-group><article-title>Reviewer #3 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In this manuscript, the authors report the first evidence of Nav1.5 regulation by a long noncoding RNA, LncRNA-DACH1, and suggest its implication in the reduction in sodium current observed in heart failure. Since no direct interaction is observed between Nav1.5 and the LncRNA, they propose that the regulation is via dystrophin and targeting of Nav1.5 to the plasma membrane.</p><p>Strengths:</p><p>(1) First evidence of Nav1.5 regulation by a long noncoding RNA.</p><p>(2) Implication of LncRNA-DACH1 in heart failure and mechanisms of arrhythmias.</p><p>(3) Demonstration of LncRNA-DACH1 binding to dystrophin.</p><p>(4) Potential rescuing of dystrophin and Nav1.5 strategy.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89690.4.sa4</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pan</surname><given-names>Zhenwei</given-names></name><role specific-use="author">Author</role><aff><institution>Harbin Medical University</institution><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Xue</surname><given-names>Genlong</given-names></name><role specific-use="author">Author</role><aff><institution>First Affiliated Hospital of Dalian Medical University</institution><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Jiming</given-names></name><role specific-use="author">Author</role><aff><institution>Harbin Medical University</institution><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Yang</given-names></name><role specific-use="author">Author</role><aff><institution>Harbin Medical University</institution><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Ying</given-names></name><role specific-use="author">Author</role><aff><institution>Harbin Medical University</institution><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Ruixin</given-names></name><role specific-use="author">Author</role><aff><institution>Harbin Medical University</institution><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Desheng</given-names></name><role specific-use="author">Author</role><aff><institution>Harbin Medical University</institution><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Tian</surname><given-names>Tao</given-names></name><role specific-use="author">Author</role><aff><institution>Harbin Medical University</institution><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Jialiang</given-names></name><role specific-use="author">Author</role><aff><institution>Harbin Medical University</institution><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Xiaofang</given-names></name><role specific-use="author">Author</role><aff><institution>Harbin Medical University</institution><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Changzhu</given-names></name><role specific-use="author">Author</role><aff><institution>Harbin Medical University</institution><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Xingda</given-names></name><role specific-use="author">Author</role><aff><institution>Harbin Medical University</institution><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Jiqin</given-names></name><role specific-use="author">Author</role><aff><institution>Harbin Medical University</institution><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Shen</surname><given-names>Kewei</given-names></name><role specific-use="author">Author</role><aff><institution>Harbin Medical University</institution><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Yang</given-names></name><role specific-use="author">Author</role><aff><institution>Harbin Medical University</institution><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Xuening</given-names></name><role specific-use="author">Author</role><aff><institution>Harbin Medical University</institution><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Guohui</given-names></name><role specific-use="author">Author</role><aff><institution>Harbin Medical University</institution><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Xuan</surname><given-names>Lina</given-names></name><role specific-use="author">Author</role><aff><institution>Harbin Medical University</institution><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Shan</surname><given-names>Hongli</given-names></name><role specific-use="author">Author</role><aff><institution>Shanghai University of Engineering Sciences</institution><addr-line><named-content content-type="city">Shanghai</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Baofeng</surname><given-names>Yang</given-names></name><role specific-use="author">Author</role><aff><institution>Harbin Medical University</institution><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Lu</surname><given-names>Yanjie</given-names></name><role specific-use="author">Author</role><aff><institution>Harbin Medical University</institution><addr-line><named-content content-type="city">Harbin</named-content></addr-line><country>China</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the previous reviews.</p><disp-quote content-type="editor-comment"><p><bold>eLife assessment</bold></p><p>This study presents an important contribution to cardiac arrhythmia research by demonstrating long noncoding RNA Dachshund homolog 1 (lncDACH1) tunes sodium channel functional expression and affects cardiac action potential conduction and rhythms. The evidence supporting the major claims are solid. The work will be of broad interest to cell biologists and cardiac electrophysiologists.</p><p><bold>Public Reviews:</bold></p><p><bold>Reviewer #1 (Public Review):</bold></p><p>Summary:</p><p>In this study, the authors show that a long-non coding RNA lncDACH1 inhibits sodium currents in cardiomyocytes by binding to and altering the localization of dystrophin. The authors use a number of methodologies to demonstrate that lncDACH1 binds to dystrophin and disrupt its localization to the membrane, which in turn downregulates NaV1.5 currents. Knockdown of lncDACH1 upregulates NaV1.5 currents. Furthermore, in heart failure, lncDACH1 is shown to be upregulated which suggests that this mechanism may have pathophysiological relevance.</p><p>Strengths:</p><p>(1) This study presents a novel mechanism of Na channel regulation which may be pathophysiologically important.</p><p>(2) The experiments are comprehensive and systematically evaluate the physiological importance of lncDACH1.</p><p><bold>Reviewer #2 (Public Review):</bold></p><p>This manuscript by Xue et al. describes the effects of a long noncoding RNA, lncDACH1, on the localization of Nav channel expression, the magnitude of INa, and arrhythmia susceptibility in the mouse heart. Because lncDACH1 was previously reported to bind and disrupt membrane expression of dystrophin, which in turn is required for proper Nav1.5 localization, much of the findings are inferred through the lens of dystrophin alterations.</p><p>The results report that cardiomyocyte-specific transgenic overexpression of lncDACH1 reduces INa in isolated cardiomyocytes; measurements in whole heart show a corresponding reduction in conduction velocity and enhanced susceptibility to arrhythmia. The effect on INa was confirmed in isolated WT mouse cardiomyocytes infected with a lncDACH1 adenoviral construct. Importantly, reducing lncDACH1 expression via either a cardiomyocyte-specific knockout or using shRNA had the opposite effect: INa was increased in isolated cells, as was conduction velocity in heart. Experiments were also conducted with a fragment of lnDACH1 identified by its conservation with other mammalian species. Overexpression of this fragment resulted in reduced INa and greater proarrhythmic behavior. Alteration of expression was confirmed by qPCR.</p><p>The mechanism by which lnDACH1 exerts its effects on INa was explored by measuring protein levels from cell fractions and immunofluorescence localization in cells. In general, overexpression was reported to reduce Nav1.5 and dystrophin levels and knockout or knockdown increased them.</p><p>The strengths of this manuscript include convincing evidence of a link between lncDACH1 and Na channel function. The identification of a lncDACH1 segment conserved among mammalian species is compelling. The observation that lncDACH1 is increased in a heart failure model and provides a plausible hypothesis for disease mechanism.</p><p>One limitation of the fractionation approach is the uncertain disposition of Na channel protein deemed &quot;cytoplasmic.&quot; It seems likely that the membrane fraction includes ER membrane. The signal may reasonably be attributed to Na channel protein in stalled transport vesicles, or alternatively in stress granules, but this was not directly addressed.</p><p><bold>Reviewer #3 (Public Review):</bold></p><p>Summary:</p><p>In this manuscript, the authors report the first evidence of Nav1.5 regulation by a long noncoding RNA, LncRNA-DACH1, and suggest its implication in the reduction in sodium current observed in heart failure. Since no direct interaction is observed between Nav1.5 and the LncRNA, they propose that the regulation is via dystrophin and targeting of Nav1.5 to the plasma membrane.</p><p>Strengths:</p><p>(1) First evidence of Nav1.5 regulation by a long noncoding RNA.</p><p>(2) Implication of LncRNA-DACH1 in heart failure and mechanisms of arrhythmias.</p><p>(3) Demonstration of LncRNA-DACH1 binding to dystrophin.</p><p>(4) Potential rescuing of dystrophin and Nav1.5 strategy.</p><p>Weaknesses:</p><p>(1) The fact that the total Nav1.5 protein is reduced by 50% which is similar to the reduction in the membrane reduction questions the main conclusion of the authors implicating dystrophin in the reduced Nav1.5 targeting. The reduction in membrane Nav1.5 could simply be due to the reduction in total protein.</p><p><bold>Recommendations for the authors:</bold></p><p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p><p>Weaknesses:</p><p>(1) What is indicated by the cytoplasmic level of NaV1.5, a transmembrane protein?</p><p>This is still confusing. Since Nav1.5 is an integral membrane protein, I am not sure what is really meant here by cytosolic fraction. From the workflow, it seems a separate organelle fraction is also collected. Is the amount of Nav1.5 in this fraction (which I assume includes for e.g. lysosome) also increased with lncDACH1? I recommend the authors to refer to the Nav channels not at the plasma membrane as 'intracellular' rather than 'cytoplasmic'.</p></disp-quote><p>Thanks for the insightful comment. We completely agree. Accordingly, we have changed “cytoplasmic” to “ intracellular“.</p><disp-quote content-type="editor-comment"><p>Line 226. &quot;In consistent with the results&quot; Perhaps unnecessary to have &quot;in&quot;</p></disp-quote><p>Thank you for the insightful comment. We have corrected it.</p><disp-quote content-type="editor-comment"><p>Line 228. Is it optimal or optical?</p></disp-quote><p>Sorry for the mistake, it should be optical. We have corrected it.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Recommendations For The Authors):</bold></p><p>I still have an issue with the total reduction in Nav1.5 which is about the same as the reduction in membrane and currents. The authors argue that there is an increase in cytoplasmic Nav1.5. However the controls that they provide for membrane and cytoplasmic fractions are not convincing.</p></disp-quote><p>Thank you for the insightful comment. We can not rule out the possibility that the reduction in membrane Nav1.5 maybe be due to the reduction in total protein. Our data indicates that the membrane and total protein levels of Nav1.5 were reduced by 50%. However, the intracellular Nav1.5 was not decreased, but increased in the hearts of lncDACH1-TG mice than WT controls, which indicates that the intracellular Nav1.5 failed to traffic to the membrane.</p></body></sub-article></article>